WO2018123873A1 - Composition for promoting perspiration - Google Patents
Composition for promoting perspiration Download PDFInfo
- Publication number
- WO2018123873A1 WO2018123873A1 PCT/JP2017/046151 JP2017046151W WO2018123873A1 WO 2018123873 A1 WO2018123873 A1 WO 2018123873A1 JP 2017046151 W JP2017046151 W JP 2017046151W WO 2018123873 A1 WO2018123873 A1 WO 2018123873A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- sweating
- promoting
- vitamin
- milk protein
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 117
- 230000001737 promoting effect Effects 0.000 title claims abstract description 109
- 102000014171 Milk Proteins Human genes 0.000 claims abstract description 67
- 108010011756 Milk Proteins Proteins 0.000 claims abstract description 67
- 235000021239 milk protein Nutrition 0.000 claims abstract description 67
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 230000035900 sweating Effects 0.000 claims description 125
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 66
- 230000037396 body weight Effects 0.000 claims description 36
- 235000013305 food Nutrition 0.000 claims description 36
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 32
- 229930003268 Vitamin C Natural products 0.000 claims description 32
- 239000011718 vitamin C Substances 0.000 claims description 32
- 235000019154 vitamin C Nutrition 0.000 claims description 32
- 108010046377 Whey Proteins Proteins 0.000 claims description 29
- 102000007544 Whey Proteins Human genes 0.000 claims description 28
- 206010019345 Heat stroke Diseases 0.000 claims description 24
- 235000019156 vitamin B Nutrition 0.000 claims description 23
- 239000011720 vitamin B Substances 0.000 claims description 23
- 235000021119 whey protein Nutrition 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 18
- 229940088594 vitamin Drugs 0.000 claims description 17
- 229930003231 vitamin Natural products 0.000 claims description 17
- 235000013343 vitamin Nutrition 0.000 claims description 17
- 239000011782 vitamin Substances 0.000 claims description 17
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 15
- 230000037406 food intake Effects 0.000 claims description 7
- 235000012631 food intake Nutrition 0.000 claims 1
- 102000011632 Caseins Human genes 0.000 description 22
- 108010076119 Caseins Proteins 0.000 description 22
- 230000036760 body temperature Effects 0.000 description 22
- 235000012054 meals Nutrition 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 239000005018 casein Substances 0.000 description 15
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 14
- 235000021240 caseins Nutrition 0.000 description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 239000007857 degradation product Substances 0.000 description 12
- 230000017854 proteolysis Effects 0.000 description 12
- 235000013361 beverage Nutrition 0.000 description 10
- 238000004806 packaging method and process Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 235000010374 vitamin B1 Nutrition 0.000 description 9
- 239000011691 vitamin B1 Substances 0.000 description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 8
- 230000002354 daily effect Effects 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- 210000004243 sweat Anatomy 0.000 description 8
- 229930003270 Vitamin B Natural products 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 235000019164 vitamin B2 Nutrition 0.000 description 7
- 239000011716 vitamin B2 Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 6
- 229930003451 Vitamin B1 Natural products 0.000 description 6
- 229930003471 Vitamin B2 Natural products 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000011068 loading method Methods 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 6
- 229960002477 riboflavin Drugs 0.000 description 6
- 229960003495 thiamine Drugs 0.000 description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 239000005862 Whey Substances 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 235000013351 cheese Nutrition 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229940055726 pantothenic acid Drugs 0.000 description 4
- 235000019161 pantothenic acid Nutrition 0.000 description 4
- 239000011713 pantothenic acid Substances 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000011726 vitamin B6 Substances 0.000 description 4
- 235000019158 vitamin B6 Nutrition 0.000 description 4
- YVGGHNCTFXOJCH-UHFFFAOYSA-N DDT Chemical compound C1=CC(Cl)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(Cl)C=C1 YVGGHNCTFXOJCH-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000008816 organ damage Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 235000014059 processed cheese Nutrition 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 235000013547 stew Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 206010065713 Gastric Fistula Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 241001312569 Ribes nigrum Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940064452 artec Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012813 breadcrumbs Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000012839 cake mixes Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000504 effect on taste Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- -1 etc.) Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 208000029015 exercise-induced malignant hyperthermia Diseases 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 235000014109 instant soup Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000020200 pasteurised milk Nutrition 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 235000015598 salt intake Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001331 thermoregulatory effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
- 235000021247 β-casein Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Definitions
- the present invention relates to a composition for promoting sweating in a hot environment such as summer.
- Patent Document 1 As measures against heat stroke, in addition to devising the living environment and clothes, intake of diligent water and salt is recommended as a hydration during exercise, for example, a function that can replenish water and mineral components lost due to sweating during exercise As a typical beverage, a soft drink containing a specific sugar content and sodium has been reported (Patent Document 1).
- composition for promoting sweating that can promote sweating even in non-exercise in a hot environment and that can be eaten easily.
- Non-patent Document 1 Effects on heat acclimatization when taking dietary interventions that adjust the ingredients of the meal and enhance protein and vitamin B in the whole meal without giving exercise load.
- objective evaluation items such as the depth body temperature increase rate and ⁇ sweating results indicate that the intervention diet group and the control diet group There was no difference between them, and adaptability of the body in a hot environment was not confirmed.
- what kind of protein is not prescribed
- regulated as the protein of this literature no composition for promoting sweating that can effectively promote sweating even in a hot environment even during non-exercises has been reported.
- the present inventors now promote sweating when ingesting a milk protein, preferably a composition comprising milk protein and vitamins B and / or vitamin C, even in a hot environment, even when not exercising. Unexpectedly, we found a new composition for promoting sweating. Further, this composition for promoting sweating was free from bitterness, and could be added to a normal meal and consumed easily. The present invention is based on these findings.
- an object of the present invention is to provide a composition for promoting sweating that can promote sweating in a hot environment.
- a composition for promoting sweating in a hot environment comprising milk protein as an active ingredient.
- the composition for promoting sweating according to (1) further comprising vitamin Bs.
- the composition for promoting sweating according to (1) or (2) further comprising vitamin C.
- the composition for promoting sweating according to any one of (1) to (3) which is used during non-exercise.
- the composition for promoting sweating according to any one of (1) to (4) wherein the daily intake is 0.5 g or more / kg body weight as the amount of milk protein.
- Sweating promotion according to any one of (1) to (6) comprising a unit packaging form per serving, wherein the unit packaging form contains 30 g or more of milk protein as a single meal intake Composition.
- the composition for promoting sweating according to any one of (1) to (7) which is used for preventing non-working heat stroke.
- a method for promoting sweating in a hot environment comprising allowing a subject in need thereof to take an effective amount of a composition comprising milk protein.
- the composition comprises at least one selected from the group consisting of vitamin Bs and vitamin C.
- the composition for promoting sweating of the present invention realizes an action capable of promoting sweating in a hot environment even when not exercising, and can be eaten easily. Therefore, the composition for promoting sweating of the present invention can be expected to have a body temperature regulating effect by promoting sweating even when not exercising, and is therefore advantageous in that it can provide a composition for preventing non-working heat stroke. is there.
- FIG. 1 is a graph showing the amount of change in the average increase in deep body temperature in a hot environment between a group that has taken a composition for promoting sweating and a group that has not taken it.
- FIG. 2 is a graph showing the average amount of sweat perspiration (mg / cm 2 ) in a hot environment between a group that has taken a composition for promoting sweating and a group that has not taken it.
- composition for promoting sweating of the present invention comprises milk protein as an active ingredient.
- An active ingredient means an ingredient required for exerting an effect of promoting sweating of an intake subject in a hot environment.
- Heat environment refers to a hot environment that affects the body, such as summer heat.
- a high temperature and high humidity environment such as indoors where the temperature is around 38 ° C. and the humidity is around 60.0%, and the heat index ((WBGT (wet bulb black temperature) Wet Globe Temperature)) is 25 in daily life.
- WBGT wet bulb black temperature
- Heat stroke is a general term for organ damage caused by deficiencies in the body's water and electrolytes (such as sodium and potassium) and hyperthermia itself, which occurs in a hot environment. Heat stroke is divided into exertional heat stroke and non-working heat stroke. being classified.
- Non-working heat stroke is a heat stroke in daily life, such as onset in a midsummer car with long baths, saunas, and air conditioners, or on extremely hot and tropical nights every day. It is a symptom that gradually worsens over several days, and is likely to affect older people, infants, and infants mainly indoors.
- the hot environment is a non-exercise hot environment.
- the subject ingesting the composition for promoting sweating of the present invention is not particularly limited as long as it has a sweat gland that requires body temperature adjustment by promoting sweating in a hot environment.
- the target includes not only humans but also animals other than humans (for example, domestic animals such as horses and cows, pets such as dogs and cats, appreciation animals kept in zoos, etc.).
- the composition for promoting sweating of the present invention can promote sweating even when not exercising.
- “when not exercising” refers to a state where there is no sudden increase in body temperature due to energy conversion of carbohydrates, lipids, and proteins due to exercise, and daily life such as long baths, saunas, and air conditioners are exhausted. Includes exposure to midsummer cars, hot days, and tropical nights.
- the sweating promoting effect means that the composition for promoting sweating of the present invention promotes sweating even in a hot environment even when not exercising.
- the sweating promoting effect can be confirmed by measuring the amount of sweating as shown in Example 1 to be described later. Specifically, in the adaptability test in a hot environment where no exercise load is applied, the start of sauna load is started. After 20 minutes, it can be determined that the sweating average increase when ingested is higher than that when the composition for promoting perspiration of the present invention is not ingested. See Example 1).
- milk protein used in the present invention is not particularly limited as long as it is a milk-derived protein.
- whey protein whey protein
- casein protein whey protein degradation product
- casein protein degradation product peptide
- examples include those containing a non-protein nitrogen component at a specific concentration (content), and preferably a whey protein in terms of good solubility.
- “Milk protein” is a mixture of whey protein, casein protein, whey protein degradation product, casein protein degradation product, peptide, or non-protein nitrogen component that has been separately separated and purified to a specific concentration. May contain whey protein, casein protein, whey proteolysate, casein proteolysate, peptide, or non-protein nitrogen component at a specific concentration, which may or may not be separately separated or purified You may use a raw material (material), food-drinks, etc. At this time, the “milk protein” used in the present invention does not require a separation step or purification step of whey protein, casein protein, whey protein degradation product, casein protein degradation product, peptide, or non-protein nitrogen component.
- the main ingredients are foods and foods that contain whey protein, casein protein, whey protein degradation product, casein protein degradation product, or peptide and non-protein nitrogen components. Accordingly, it is preferable to use separately purified whey protein, casein protein, whey protein degradation product, casein protein degradation product, or peptide and non-protein nitrogen components so as to have a specific concentration.
- Whey proteins separated and purified separately from casein protein include, for example, whey stock solutions (sweet whey, acid whey, etc.), concentrates, dried products (whey powder), frozen products, etc. A reducing solution or the like can be used. Furthermore, desalted whey, whey protein concentrate (WPC), whey protein purified product (WPI), ⁇ -lactalbumin ( ⁇ -La), ⁇ -lactoglobulin ( ⁇ -Lg), immunoglobulin, lactoferrin, etc., and These reducing solutions can be used. As the whey protein degradation product, a hydrolyzate of whey protein separated and purified separately from the above casein protein, a reduced solution thereof, and the like can be used.
- Casein protein separated and purified separately from whey protein includes, for example, casein isolate (natural cheese such as fresh cheese, sodium caseinate, calcium caseinate), its concentrate, its dried product, its Frozen products and the like, and reducing solutions thereof can be used. Furthermore, purified products such as ⁇ -casein, ⁇ -casein, and ITA-casein, and reducing solutions thereof can be used. In addition, as a casein protein degradation product, a hydrolyzate of casein protein separated and purified separately from the whey protein, a reduced solution thereof, and the like can be used.
- raw materials and foods and drinks that already contain whey protein and casein protein at specific concentrations include, for example, raw milk, pasteurized milk (such as milk), skim milk, component-adjusted milk, processed milk, and dairy products (concentrated milk).
- powdered milk, condensed milk, fermented milk (yogurt, natural cheese, etc.), lactic acid bacteria beverages, processed cheeses, ice creams, creams), milk protein concentrate (MPC), its concentrate, its dried product, its frozen product, A hydrolyzate thereof, a reducing solution thereof or the like can be used. At this time, you may obtain and use a commercial item for these, and may prepare and use it for themselves.
- the composition for promoting sweating of the present invention contains milk protein as an active ingredient, the composition is better absorbed into the body than general proteins, and increases blood flow and retains water for a long time. Therefore, even if the intake period is short, a high sweating promoting effect can be obtained.
- the composition for promoting sweating of the present invention may further contain vitamins B and / or vitamin C.
- Vitamin B used in the present invention includes eight types of vitamins B1, B2, B6, B12, niacin, pantothenic acid, folic acid and biotin. These may be used alone or in combination of two or more.
- the vitamin Bs are preferably vitamins B1, B2, B6, B12, niacin, pantothenic acid and folic acid, more preferably vitamins B1, B2, B6 and niacin. Vitamin Bs can assist milk protein metabolism by being taken with milk protein.
- the total amount of vitamin B is desirably added so that the ratio of vitamin B: milk protein amount is from 1: 30000 to 1: 1000, preferably from 2: 30000 to 2: Add to 1000.
- the vitamin B is vitamin B1 and / or vitamin B2
- the vitamin B1 and / or vitamin B2: milk protein amount ratio is 1: 30000 to 1: 1000. Is added so as to be 2: 30000-2: 1000.
- Vitamin C used in the present invention is a kind of water-soluble vitamin, and chemically refers to L-ascorbic acid. Vitamin C can promote protein synthesis. Vitamin C may be natural or synthesized.
- Vitamin C is preferably added so that the ratio of vitamin C: milk protein to the milk protein content is 1: 3000, more preferably 1: 300, and even more preferably 1:30. Add to.
- the composition for promoting sweating of the present invention comprises milk protein, vitamin Bs, and vitamin C as active ingredients.
- the composition for promoting sweating of the present invention comprises milk protein, one or more vitamin Bs selected from vitamin B1, vitamin B2, niacin, vitamin B6, folic acid and pantothenic acid, and vitamins. C as an active ingredient.
- the composition for promoting sweating of the present invention is effective in milk protein, at least one vitamin B selected from vitamin B1, vitamin B2, niacin, and vitamin B6, and vitamin C. Comprising as an ingredient.
- the composition for promoting sweating of the present invention comprises milk protein, one or more vitamin Bs selected from vitamin B1 and vitamin B2, and vitamin C as active ingredients.
- the composition for promoting sweating of the present invention may contain other components as long as the effect of promoting sweating is not hindered.
- other components include sodium, potassium, iron, calcium, and magnesium.
- the composition for promoting perspiration of the present invention may contain a protein other than milk protein and an amino acid.
- the method (or method of administration) for ingesting the composition for promoting sweating of the present invention to a subject can be appropriately selected from oral ingestion (or oral administration), enteral administration, gastric fistula and the like depending on the subject and application. Although it can, it is preferably taken orally (or orally).
- composition for promoting sweating according to the present invention can prevent perspiration from being greatly changed even in a hot environment by promoting sweating. That is, the composition for promoting sweating of the present invention can also be used as a composition for regulating body temperature in a hot environment.
- the composition for promoting sweating of the present invention can regulate the deep body temperature by promoting sweating, and thus can prevent and alleviate heat stroke. That is, the composition for promoting sweating of the present invention can be used as a prophylactic and / or therapeutic agent for heat stroke, and preferably as a prophylactic and / or therapeutic agent for non-working heat stroke.
- the composition for promoting sweating of the present invention can promote sweating, a detox effect for beauty purposes such as elimination of swelling in a sauna or bath can be obtained. That is, the composition for promoting sweating of the present invention can also be used as a composition for promoting detox and a composition for improving swelling.
- “detox” means the action of excreting toxins from the body. That is, it means that harmful substances and toxins gradually accumulated in the body by ingesting a trace amount from the environment such as food and air are discharged outside the body by sweating, defecation and urination.
- composition for promoting sweating of the present invention may be in any form as long as the effect is exerted, for example, solid (powder, granule, capsule, block, etc.), liquid, gel , Paste, paste and the like.
- the composition for promoting sweating of the present invention is in a solid form in that it can improve storage stability and portability.
- the composition for promoting sweating of the present invention contains milk protein, and the daily intake is 0.5 g or more / kg body weight as the protein amount of milk protein. Ingested, preferably 0.5 to 10 g / kg body weight, more preferably 0.5 to 8 g / kg body weight, still more preferably 0.5 to 6 g / kg body weight. According to another preferred embodiment of the present invention, the composition for promoting sweating of the present invention is ingested so that the protein content of milk protein is preferably 0.5 g / kg body weight or more per serving.
- the representative weight of the subject is estimated to be 60 kg.
- the composition for promoting sweating of the present invention comprises milk protein and vitamins B and / or vitamin C, and the daily intake is 5 g or more as the amount of milk protein.
- / Kg body weight is desirable, preferably 5 to 10 g / kg body weight, more preferably 5 to 8 g / kg body weight, still more preferably 5 to 6 g / kg body weight.
- the composition for promoting sweating of the present invention comprises milk protein and vitamins B and / or vitamin C, and the daily intake is the amount of milk protein.
- the body weight is 0.5 g or more / kg body weight, preferably 0.5 to 10 g / kg body weight, more preferably 0.5 to 8 g / kg body weight, further preferably 0.5 to Ingested to reach 6 g / kg body weight.
- the composition for promoting sweating of the present invention comprises milk protein and vitamins B and / or vitamin C, and the protein content of the milk protein is per serving, Preferably, it is taken so as to be 0.5 g or more / kg body weight, more preferably 0.5 to 1.6 g / kg body weight, still more preferably 0.5 to 1.2 g / kg body weight, more preferably Ingested so as to be 0.5 to 1 g / kg body weight, more preferably 0.5 to 0.7 g / kg body weight.
- vitamin Bs are desirably ingested so as to be 0.0015 mg / kg body weight or more, preferably 0.0015 to 2 mg / kg body weight, more preferably 0.015 to 1 mg / kg body weight, More preferably, it is taken to be 0.03 to 0.7 mg / kg body weight, and vitamin C is desirably taken to be 0.15 mg or more / kg body weight, preferably 0.8 to 50 mg. / Kg body weight, more preferably 1.5 to 35 mg / kg body weight, still more preferably 8 to 25 mg / kg body weight.
- the representative weight of the subject is estimated to be 60 kg.
- the composition for promoting sweating of the present invention comprises a unit packaging form per serving, and the amount of milk protein as a meal intake is included in the unit packaging form. And adjusted to 30 g or more, preferably 30 to 100 g, more preferably 30 to 80 g, still more preferably 30 to 60 g, still more preferably 30 to 40 g.
- “Contains a unit packaging form per meal” is a form in which the intake per meal is determined in advance, for example, as a food that can be ingested in a specific amount, not only general foods but also health supplements , Health functional foods, supplements, beverages (drinks, etc.).
- unit packaging form per meal for example, in the case of powdery, granular, capsule, block-like solid food, liquid beverage, gel-like, paste-like, paste-like jelly, Forms that can specify a specific amount (dose) in packaging containers such as metal cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage) , Dose) can be specified on a packaging container or a homepage, and the specific amount can be specified.
- dose in packaging containers such as metal cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage) , Dose) can be specified on a packaging container or a homepage, and the specific amount can be specified.
- the composition for promoting sweating of the present invention further comprises vitamin Bs and / or vitamin C in a unit package form per serving, in which case the vitamin Bs Is preferably adjusted to 0.1 mg or more, and preferably 0.1 to 100 mg, more preferably 1 to 50 mg, and even more preferably 2 to 40 mg.
- the intake per serving is preferably adjusted to 10 mg or more, preferably 50 to 3000 mg, more preferably 100 to 2000 mg, and still more preferably 500 to 1500 mg.
- the protein amount is 30 to 100 g of milk protein, preferably
- the composition containing the milk protein and vitamins B and / or vitamin C is used as a volume (dose) per serving, for example, in a form (filled) in a film container.
- the amount of protein (30 to 100 g of milk protein, preferably a composition containing the milk protein and vitamins B and / or vitamin C) may be displayed on a packaging container or homepage. And the form put into the packaging container etc. of a large capacity
- the period during which the composition for promoting sweating of the present invention is ingested is preferably before exposure to a hot environment, preferably 3 days before exposure, more preferably 5 days before exposure, and even more preferably 7 days before exposure.
- the longer the intake period the better the blood flow in the body can be increased, and as a result, the sweating promoting effect is enhanced.
- the composition for promoting sweating of the present invention can be used alone as it is, but as long as the function of promoting sweating is exhibited, various oral intakes such as foods and pharmaceuticals can be used.
- a composition having a sweating promoting effect for example, a pharmaceutical composition or a food composition
- the composition for promoting sweating of the present invention does not impair the taste even when added to a meal, it can be easily ingested by adding it to a normal meal or a drink.
- the food composition of the present invention in the food composition of the present invention, as other components, for example, water, carbohydrates, lipids, vitamins, minerals, organic acids, organic bases, fruit juices, and flavors Etc. can be used. These other components may be used in combination of two or more thereof, or a synthetic product thereof and / or a food containing a large amount thereof may be used.
- the sugar is not particularly limited as long as it is used as a food composition.
- sugar processed starch (in addition to text phosphorus, soluble starch, British starch, oxidized starch, starch ester, starch ether, etc.), And dietary fiber.
- the lipid is not particularly limited as long as it is used as a food composition.
- animal oils such as lard, fish oil and the like, fractionated oils, hydrogenated oils and transesterified oils; and palm oil , Vegetable oils such as safflower oil, corn oil, rapeseed oil, coconut oil, fractionated oils thereof, hydrogenated oils, and transesterified oils.
- the minerals are not particularly limited as long as they are used as food compositions, and examples thereof include calcium, potassium, magnesium, sodium, copper, iron, copper, phosphorus, manganese, and selenium.
- the organic acid is not particularly limited as long as it is used as a food composition, and examples thereof include malic acid, citric acid, lactic acid, and tartaric acid.
- the organic base is not particularly limited as long as it is used as a food composition, and examples thereof include histidine.
- the fruit juice is not particularly limited as long as it is used as a food composition, and examples thereof include grape, orange, mango, grapefruit, blueberry, strawberry, cassis, apple, and pineapple.
- a food for promoting sweating comprising milk protein, preferably milk protein and vitamins B and / or vitamin C as active ingredients.
- the form of “food” is not particularly limited as long as it can be taken orally, such as a solution, a suspension, an emulsion, a powder, and a solid molded product.
- instant foods such as retort foods, canned foods, microwave foods, instant soups, freeze-dried foods; coffee drinks, tea drinks, powdered drinks, concentrated drinks; bread, pasta, noodles, cake mixes, bread crumbs, etc.
- Flour products Flour products; cookies, biscuits, cakes, snacks, crackers, chocolates, desserts and other confectionery; cooking mixes, curry and stew ingredients; milk beverages, fermented milk (such as yogurt), lactic acid bacteria beverages, Examples include dairy products such as natural cheese, processed cheeses, creams and ice creams; processed agricultural products such as cereals; frozen foods; and liquid foods. By taking such a form, it can be taken without feeling a psychological disorder.
- Foods include health foods, functional labeling foods, dietary supplements, foods for specified health use, foods for the sick, infant formulas, milk powder for pregnant and lactating women, and promotion of sweating in hot environments It also includes those classified as foods with a label indicating that they are used for the purpose.
- a drug for promoting sweating comprising milk protein, preferably milk protein and vitamin Bs and / or vitamin C as active ingredients.
- the “medicament” (pharmaceutical composition) is prepared as an oral preparation or a parenteral preparation according to a conventional method using additives that are acceptable for formulation.
- the pharmaceutical is an oral preparation, it should be in the form of a solid preparation such as a tablet, powder, fine granule, granule, capsule, pill or sustained release, or a liquid preparation such as a solution, suspension or emulsion. Can take.
- a pharmaceutical when a pharmaceutical is a parenteral formulation, it can take the form of an injection or a suppository.
- an oral preparation is preferable for a pharmaceutical product.
- additives that are acceptable for formulation include, for example, excipients, stabilizers, preservatives, wetting agents, emulsifiers, lubricants, sweeteners, coloring agents, fragrances, buffers, antioxidants. Agents, pH adjusters and the like.
- the pharmaceutical agent of the present invention can be used for the treatment or prevention of diseases requiring the promotion of sweating, specifically heat stroke (preferably non-working heat stroke).
- the composition for promoting sweating of the present invention is an effective amount of a composition comprising milk protein, preferably milk protein and vitamins B and / or vitamin C, and any orally acceptable.
- a composition for promoting sweating comprising blending an effective amount of a milk protein, preferably a milk protein and a composition comprising vitamin Bs and / or vitamin C.
- a manufacturing method is provided.
- an effective amount of a composition comprising milk protein, preferably milk protein and vitamins B and / or vitamin C, is ingested by a subject in a hot environment in need thereof.
- a method of promoting perspiration comprising the step of:
- the method for promoting sweating excludes medical practice for humans.
- the “medical action for humans” means an action that requires a doctor or the like to ingest (administer) a medicine to a human.
- the subject is preferably a healthy person.
- the method for promoting sweating of the present invention may be used for improving a disease or a condition associated with a decrease in sweating function in a subject. Therefore, the method for promoting sweating of the present invention is preferably a method for ameliorating a disease or condition associated with reduced sweat function, more preferably a method for improving heat stroke, and more preferably a method for improving non-working heat stroke.
- “amelioration” includes not only treating an established disease or condition, but also preventing a disease or condition that may be established in the future.
- the method for promoting sweating of the present invention can be carried out according to the description of the composition for promoting sweating in the present specification.
- milk protein is ingested (administered) so that the protein content per meal is preferably 0.5 g / kg body weight or more, More preferably, it is 0.5 to 1.6 g / kg body weight, more preferably 0.5 to 1.2 g / kg body weight, more preferably 0.5 to 1 g / kg body weight, still more preferably 0.5 to 0. It can be ingested (administered) to a weight of 7 g / kg.
- the typical weight of the subject is estimated to be about 60 kg.
- the milk protein in the method for promoting sweating of the present invention, can be ingested so that the protein content is 30 g or more per meal, specifically, 30 to 100 g. It can be ingested so that it is preferably 30 to 80 g, more preferably 30 to 60 g, and still more preferably 30 to 40 g.
- the use of milk protein to promote sweating is for consumption with vitamins B and / or vitamin C.
- the use of the invention is a non-therapeutic use.
- the use of milk protein for the production of a composition for promoting sweating is provided.
- the use is for consumption with vitamins B and / or vitamin C.
- the use is for the production of a sweat promoting food or medicament.
- a milk protein for promoting sweating is provided.
- the milk protein is used with vitamins B and / or vitamin C.
- Example 1 Adaptability test in a hot environment
- a composition for promoting sweating consisting of the composition shown in the following table (and daily intake).
- the adaptability of the body at a sauna room temperature of 38 ° C. and a humidity of 60% was examined.
- vitamin B those containing vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid and pantothenic acid as constituent components were used.
- Ingestion of the composition for promoting sweating was performed by adding it to a normal meal. Specifically, the following method was used.
- Subjects The subjects were 10 healthy male university students with written consent. Statistical software Stat Flex ver. 6 (Artec Co., Ltd.), 5 of the subjects were the stage I intervention group and the remaining 5 were the stage II intervention group.
- the study design was a prospective intervention study and a crossover study.
- Stage I subjects ingested a diet (test food) supplemented with a sweat-promoting composition in the Stage I intervention group, and the sweating-promoting composition in the Stage II intervention group. Not ingested (continue normal diet).
- stage II the stage I intervention group did not take the composition for promoting sweating (continued normal diet), and the stage II intervention group had the composition for promoting sweating added (Test food) was ingested.
- water and salt intake were not restricted. Alcohol consumption was prohibited.
- the far-infrared sauna load test was conducted a total of 4 times before and after the period I (first 7 days) and before and after the period II.
- the intake energy added per day when taking the test food is 139 kcal.
- Evaluation item Evaluation was performed at the time of 5 minutes, 10 minutes, 20 minutes, and 30 minutes after the start of sauna loading.
- deep body temperature was measured using a body temperature monitor (Terumo Corporation, CM-210).
- a heat flow compensation probe was used to measure the deep body temperature.
- a deep body temperature probe was attached to the forehead with tape and a band.
- As an average amount of increase in deep body temperature the average value of the deep body temperature for 3 minutes before entering the sauna is used as a reference value, and the average of the deep body temperature for 30 seconds at the time of 5 minutes, 10 minutes, 20 minutes, and 30 minutes after starting the sauna load The difference between the reference values was determined.
- the amount of sweat (mg / cm 2 / min) was measured using a sweat meter (Techno Science Co., Ltd., TPL3520).
- the sensor head was attached to the inside of the left forearm near the elbow with tape.
- the average increase in perspiration (mg / cm 2 ) is the average of perspiration for 3 minutes before entering the sauna, and it is 30 minutes each at 5 minutes, 10 minutes, 20 minutes and 30 minutes after the start of sauna loading. The difference between the average amount of sweating and the reference value was determined.
- a room temperature was set using a far-infrared sauna, natural spa, relaxing for one person (Kobe Medicare).
- the sauna room temperature was set to 38 ° C.
- a humidifier (SIS Corporation, PIA HYBRID humidifier) was used as the humidity in the sauna room.
- the humidity in the sauna room was set to be around 60.0%.
- the exposure time in the hot environment was 30 minutes, which is within the safety standards for using far-infrared saunas.
- all subjects while entering the sauna, all subjects wore commercial clothing of the same material.
- Figure 1 shows the results of changes in the average increase in deep body temperature before and after the intervention.
- the amount of change in the average increase in deep body temperature is 0.04 ⁇ 0.02 ° C. at 5 minutes after the start of sauna loading, and 0 at 10 minutes 0.08 ⁇ 0.03 ° C., 0.18 ⁇ 0.02 ° C. at 20 minutes, 0.20 ⁇ 0.02 ° C. at 30 minutes, and increased with time.
- the sweat intake composition intake group intervention
- ⁇ 0.01 ⁇ 0.04 ° C. at 5 minutes after the start of sauna loading ⁇ 0.09 ⁇ 0.05 ° C. at 20 minutes, 20 minutes It changed to 0.05 ⁇ 0.04 ° C. at the time point of ⁇ 0.06 ⁇ 0.05 ° C. at the time point of 30 minutes and hardly increased. Therefore, it was shown that the increase in deep body temperature was suppressed by ingestion of the composition for promoting sweating in a hot environment.
- Example 2 Change in taste due to addition of composition for promoting sweating
- the composition for promoting sweating used in Example 1 is added to meals (for example, soup, miso soup, stew) and beverages (for example, cafe au lait, milk tea) The effect on taste was confirmed.
- the taste was compared between a meal or beverage to which the composition for promoting sweating per day was added and a non-added meal or beverage.
- the tastes were almost the same as those of the non-added foods and beverages.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Provided is a composition for promoting perspiration with which it is possible to promote perspiration even during times of non-exercise in a hot environment. More specifically, this composition for promoting perspiration contains milk protein as an active ingredient.
Description
本特許出願は、2016年12月28日に出願された日本国特許出願第2016-256460号に基づく優先権の主張を伴うものであり、かかる先の出願における全開示内容は、引用することにより本明細書の一部とされる。
This patent application is accompanied by a priority claim based on Japanese Patent Application No. 2016-256460 filed on Dec. 28, 2016, and the entire disclosure in such earlier application is incorporated by reference. It is made a part of this specification.
技術分野
本発明は、夏場などの暑熱環境における発汗促進用組成物に関する。 TECHNICAL FIELD The present invention relates to a composition for promoting sweating in a hot environment such as summer.
本発明は、夏場などの暑熱環境における発汗促進用組成物に関する。 TECHNICAL FIELD The present invention relates to a composition for promoting sweating in a hot environment such as summer.
背景技術
近年、地球温暖化やヒートアイランド現象等により、夏の暑さによる身体への熱ストレスは大きくなってきている。このような身体に影響を与える暑さ環境、すなわち暑熱環境への曝露により、運動時での熱中症(労作性熱中症)だけでなく、猛暑日や熱帯夜など、筋肉運動の伴わない非運動時での熱中症(非労作性(古典的)熱中症)の発生が増加している。特に、非運動時に発生する熱中症は、幼児・小児や高齢者に多く見られ、年々増加傾向にある。熱中症の対策としては、住環境や服装の工夫の他、運動時には水分補給としてこまめな水分および塩分の摂取が推奨され、例えば、運動時の発汗により失われる水分やミネラル成分を補給可能な機能的飲料として、特定の糖度と、ナトリウムとを含む清涼飲料が報告されている(特許文献1)。 Background Art In recent years, due to global warming, heat island phenomenon, etc., heat stress on the body due to summer heat has been increasing. Due to exposure to the heat environment that affects the body, that is, heat environment, not only heat stroke during exercise (working heat stroke), but also during non-exercise without muscle exercise, such as extremely hot days and tropical nights The incidence of heat stroke (non-working (classical) heat stroke) is increasing. In particular, heat stroke that occurs during non-exercise is common in infants, children and the elderly, and is increasing year by year. As measures against heat stroke, in addition to devising the living environment and clothes, intake of diligent water and salt is recommended as a hydration during exercise, for example, a function that can replenish water and mineral components lost due to sweating during exercise As a typical beverage, a soft drink containing a specific sugar content and sodium has been reported (Patent Document 1).
近年、地球温暖化やヒートアイランド現象等により、夏の暑さによる身体への熱ストレスは大きくなってきている。このような身体に影響を与える暑さ環境、すなわち暑熱環境への曝露により、運動時での熱中症(労作性熱中症)だけでなく、猛暑日や熱帯夜など、筋肉運動の伴わない非運動時での熱中症(非労作性(古典的)熱中症)の発生が増加している。特に、非運動時に発生する熱中症は、幼児・小児や高齢者に多く見られ、年々増加傾向にある。熱中症の対策としては、住環境や服装の工夫の他、運動時には水分補給としてこまめな水分および塩分の摂取が推奨され、例えば、運動時の発汗により失われる水分やミネラル成分を補給可能な機能的飲料として、特定の糖度と、ナトリウムとを含む清涼飲料が報告されている(特許文献1)。 Background Art In recent years, due to global warming, heat island phenomenon, etc., heat stress on the body due to summer heat has been increasing. Due to exposure to the heat environment that affects the body, that is, heat environment, not only heat stroke during exercise (working heat stroke), but also during non-exercise without muscle exercise, such as extremely hot days and tropical nights The incidence of heat stroke (non-working (classical) heat stroke) is increasing. In particular, heat stroke that occurs during non-exercise is common in infants, children and the elderly, and is increasing year by year. As measures against heat stroke, in addition to devising the living environment and clothes, intake of diligent water and salt is recommended as a hydration during exercise, for example, a function that can replenish water and mineral components lost due to sweating during exercise As a typical beverage, a soft drink containing a specific sugar content and sodium has been reported (Patent Document 1).
非運動時での熱中症対策としても、同様の対策が行われているが、加齢による体温調節機能の衰えや幼児・小児での発汗機能の未熟さによる発汗量の低下に着目し、発汗促進による体温調節が注目されている。発汗とは汗腺の分泌亢進を意味し、汗の蒸発、すなわち気化熱によって体温を低くすることができる体温調節現象の一つである。このような発汗を促進する方法として、例えば、非重合体カテキン類を含有し、かつ、浸透圧が体液よりも低い液剤を摂取することによる発汗促進の報告がある(特許文献2)。しかしながら、このような非重合カテキン類は苦味が強く、また多量の水分も含むものであるため、毎日つづけて、簡易に摂取できるものではなく、また、カフェインなどが多量に含まれ興奮作用があるため幼児などには向かないものであった。
Similar measures have been taken to prevent heat stroke when not exercising, but focusing on the decline in the amount of sweating due to the decline in thermoregulatory function due to aging and the immaturity of sweating function in infants and children, Body temperature regulation by promotion has attracted attention. Sweating means increased secretion of sweat glands and is one of the body temperature regulation phenomena that can lower body temperature by evaporation of sweat, that is, heat of vaporization. As a method for promoting such sweating, for example, there is a report of sweating promotion by ingesting a liquid agent containing non-polymer catechins and having an osmotic pressure lower than that of body fluid (Patent Document 2). However, since such non-polymerized catechins have a strong bitter taste and contain a large amount of water, they cannot be easily ingested continuously every day, and they contain a large amount of caffeine and have an excitable action. It was not suitable for infants.
このように、暑熱環境において、非運動時であっても、発汗を促進できる、簡易に摂食可能な発汗促進用組成物は、何ら報告されていない。
As described above, there is no report on a composition for promoting sweating that can promote sweating even in non-exercise in a hot environment and that can be eaten easily.
非運動時の暑熱環境と食事に関しては、運動負荷を与えずに、食事の成分を調整して食事全体でのタンパク質およびビタミンB類を強化した介入食を摂取した場合の暑熱順化への影響の報告がある(非特許文献1)。しかしながら、非特許文献1の図3及び図4-2に示されているように、客観的な評価項目、例えば、深部体温上昇率及びΔ発汗量の結果では、介入食群と対照食群との間に差は見られず、暑熱環境下における身体の順応性は確認されなかった。また、この文献のタンパク質は、どのようなタンパク質であるのか、規定されていない。このように、暑熱環境において、非運動時であっても効果的に発汗を促進できる発汗促進用組成物は、何ら報告されていない。
Regarding non-exercise heat environment and meals, effects on heat acclimatization when taking dietary interventions that adjust the ingredients of the meal and enhance protein and vitamin B in the whole meal without giving exercise load (Non-patent Document 1). However, as shown in FIG. 3 and FIG. 4-2 of Non-Patent Document 1, objective evaluation items such as the depth body temperature increase rate and Δ sweating results indicate that the intervention diet group and the control diet group There was no difference between them, and adaptability of the body in a hot environment was not confirmed. Moreover, what kind of protein is not prescribed | regulated as the protein of this literature. Thus, no composition for promoting sweating that can effectively promote sweating even in a hot environment even during non-exercises has been reported.
本発明者らは今般、乳タンパク質、好ましくは、乳タンパク質とビタミンB類および/またはビタミンCとを含んでなる組成物を摂取すると、暑熱環境において、非運動時であっても、発汗を促進できることを予想外にも見出し、新規な発汗促進用組成物を開発した。また、この発汗促進用組成物は、苦みのないものであり、通常の食事に追加でき、簡易に摂食できるものであった。本発明は、これらの知見に基づくものである。
The present inventors now promote sweating when ingesting a milk protein, preferably a composition comprising milk protein and vitamins B and / or vitamin C, even in a hot environment, even when not exercising. Unexpectedly, we found a new composition for promoting sweating. Further, this composition for promoting sweating was free from bitterness, and could be added to a normal meal and consumed easily. The present invention is based on these findings.
従って、本発明は、暑熱環境における発汗を促進できる発汗促進用組成物を提供することをその目的とする。
Therefore, an object of the present invention is to provide a composition for promoting sweating that can promote sweating in a hot environment.
本発明によれば、以下の発明が提供される。
(1)乳タンパク質を有効成分として含んでなる、暑熱環境における発汗促進用組成物。
(2)ビタミンB類をさらに含んでなる、(1)に記載の発汗促進用組成物。
(3)ビタミンCをさらに含んでなる、(1)または(2)に記載の発汗促進用組成物。
(4)非運動時に使用するための、(1)~(3)のいずれかに記載の発汗促進用組成物。
(5)一日当たりの摂取量が、乳タンパク質の量として0.5g以上/kg体重である、(1)~(4)のいずれかに記載の発汗促進用組成物。
(6)乳タンパク質がホエイタンパク質である、(1)~(5)のいずれかに記載の発汗促進用組成物。
(7)一食当たりの単位包装形態からなり、該単位包装形態中に、一食摂取量として乳タンパク質の量として30g以上を含む、(1)~(6)のいずれかに記載の発汗促進用組成物。
(8)非労作性熱中症予防に用いられる、(1)~(7)のいずれかに記載の発汗促進用組成物。
(9)食品組成物である、(1)~(8)のいずれかに記載の発汗促進用組成物。
(10)乳タンパク質を含んでなる組成物の有効量を、それを必要とする対象に摂取させることを含んでなる、暑熱環境における発汗促進方法。
(11)前記組成物が、ビタミンB類およびビタミンCからなる群から選択される少なくとも一つを含んでなる、(10)に記載の方法。
(12)暑熱環境における発汗促進のための、乳タンパク質の使用。
(13)発汗促進用組成物の製造のための、乳タンパク質の使用。
(14)前記乳タンパク質が、ビタミンB類およびビタミンCからなる群から選択される少なくとも一つと共に使用される、(12)または(13)に記載の使用。
(15)暑熱環境における発汗を促進するための、乳タンパク質。
(16)ビタミンB類およびビタミンCからなる群から選択される少なくとも一つと共に使用される、(15)に記載の乳タンパク質。 According to the present invention, the following inventions are provided.
(1) A composition for promoting sweating in a hot environment, comprising milk protein as an active ingredient.
(2) The composition for promoting sweating according to (1), further comprising vitamin Bs.
(3) The composition for promoting sweating according to (1) or (2), further comprising vitamin C.
(4) The composition for promoting sweating according to any one of (1) to (3), which is used during non-exercise.
(5) The composition for promoting sweating according to any one of (1) to (4), wherein the daily intake is 0.5 g or more / kg body weight as the amount of milk protein.
(6) The composition for promoting sweating according to any one of (1) to (5), wherein the milk protein is whey protein.
(7) Sweating promotion according to any one of (1) to (6), comprising a unit packaging form per serving, wherein the unit packaging form contains 30 g or more of milk protein as a single meal intake Composition.
(8) The composition for promoting sweating according to any one of (1) to (7), which is used for preventing non-working heat stroke.
(9) The composition for promoting sweating according to any one of (1) to (8), which is a food composition.
(10) A method for promoting sweating in a hot environment, comprising allowing a subject in need thereof to take an effective amount of a composition comprising milk protein.
(11) The method according to (10), wherein the composition comprises at least one selected from the group consisting of vitamin Bs and vitamin C.
(12) Use of milk protein to promote sweating in a hot environment.
(13) Use of milk protein for the production of a composition for promoting sweating.
(14) The use according to (12) or (13), wherein the milk protein is used together with at least one selected from the group consisting of vitamin Bs and vitamin C.
(15) Milk protein for promoting sweating in a hot environment.
(16) The milk protein according to (15), which is used together with at least one selected from the group consisting of vitamins B and vitamin C.
(1)乳タンパク質を有効成分として含んでなる、暑熱環境における発汗促進用組成物。
(2)ビタミンB類をさらに含んでなる、(1)に記載の発汗促進用組成物。
(3)ビタミンCをさらに含んでなる、(1)または(2)に記載の発汗促進用組成物。
(4)非運動時に使用するための、(1)~(3)のいずれかに記載の発汗促進用組成物。
(5)一日当たりの摂取量が、乳タンパク質の量として0.5g以上/kg体重である、(1)~(4)のいずれかに記載の発汗促進用組成物。
(6)乳タンパク質がホエイタンパク質である、(1)~(5)のいずれかに記載の発汗促進用組成物。
(7)一食当たりの単位包装形態からなり、該単位包装形態中に、一食摂取量として乳タンパク質の量として30g以上を含む、(1)~(6)のいずれかに記載の発汗促進用組成物。
(8)非労作性熱中症予防に用いられる、(1)~(7)のいずれかに記載の発汗促進用組成物。
(9)食品組成物である、(1)~(8)のいずれかに記載の発汗促進用組成物。
(10)乳タンパク質を含んでなる組成物の有効量を、それを必要とする対象に摂取させることを含んでなる、暑熱環境における発汗促進方法。
(11)前記組成物が、ビタミンB類およびビタミンCからなる群から選択される少なくとも一つを含んでなる、(10)に記載の方法。
(12)暑熱環境における発汗促進のための、乳タンパク質の使用。
(13)発汗促進用組成物の製造のための、乳タンパク質の使用。
(14)前記乳タンパク質が、ビタミンB類およびビタミンCからなる群から選択される少なくとも一つと共に使用される、(12)または(13)に記載の使用。
(15)暑熱環境における発汗を促進するための、乳タンパク質。
(16)ビタミンB類およびビタミンCからなる群から選択される少なくとも一つと共に使用される、(15)に記載の乳タンパク質。 According to the present invention, the following inventions are provided.
(1) A composition for promoting sweating in a hot environment, comprising milk protein as an active ingredient.
(2) The composition for promoting sweating according to (1), further comprising vitamin Bs.
(3) The composition for promoting sweating according to (1) or (2), further comprising vitamin C.
(4) The composition for promoting sweating according to any one of (1) to (3), which is used during non-exercise.
(5) The composition for promoting sweating according to any one of (1) to (4), wherein the daily intake is 0.5 g or more / kg body weight as the amount of milk protein.
(6) The composition for promoting sweating according to any one of (1) to (5), wherein the milk protein is whey protein.
(7) Sweating promotion according to any one of (1) to (6), comprising a unit packaging form per serving, wherein the unit packaging form contains 30 g or more of milk protein as a single meal intake Composition.
(8) The composition for promoting sweating according to any one of (1) to (7), which is used for preventing non-working heat stroke.
(9) The composition for promoting sweating according to any one of (1) to (8), which is a food composition.
(10) A method for promoting sweating in a hot environment, comprising allowing a subject in need thereof to take an effective amount of a composition comprising milk protein.
(11) The method according to (10), wherein the composition comprises at least one selected from the group consisting of vitamin Bs and vitamin C.
(12) Use of milk protein to promote sweating in a hot environment.
(13) Use of milk protein for the production of a composition for promoting sweating.
(14) The use according to (12) or (13), wherein the milk protein is used together with at least one selected from the group consisting of vitamin Bs and vitamin C.
(15) Milk protein for promoting sweating in a hot environment.
(16) The milk protein according to (15), which is used together with at least one selected from the group consisting of vitamins B and vitamin C.
本発明の発汗促進用組成物は、暑熱環境において、非運動時であっても、発汗を促進できる作用を実現するとともに、簡易に摂食できるものである。従って、本発明の発汗促進用組成物では、非運動時であっても、発汗の促進によって体温調節作用が期待でき、従って、非労作性熱中症の予防用組成物を提供できる点で有利である。
The composition for promoting sweating of the present invention realizes an action capable of promoting sweating in a hot environment even when not exercising, and can be eaten easily. Therefore, the composition for promoting sweating of the present invention can be expected to have a body temperature regulating effect by promoting sweating even when not exercising, and is therefore advantageous in that it can provide a composition for preventing non-working heat stroke. is there.
本発明の発汗促進用組成物は、乳タンパク質を有効成分として含んでなる。
The composition for promoting sweating of the present invention comprises milk protein as an active ingredient.
「有効成分」とは、暑熱環境において、摂取対象の発汗を促進する効果を奏する上で必要とされる成分のことを意味する。
“An active ingredient” means an ingredient required for exerting an effect of promoting sweating of an intake subject in a hot environment.
「暑熱環境」とは、夏の暑さといった身体に影響を与える暑さ環境をいう。例えば、温度が38℃前後で湿度が60.0%前後の室内のような高温高湿環境や、暑さ指数((WBGT(湿球黒球温度)Wet Bulb Globe Temperature))が日常生活において25度以上、運動環境下において21度以上である環境を指す。暑熱環境下で起こる体内の水分や電解質(ナトリウムやカリウムなど)の欠乏や高体温そのものによる臓器障害の総称を熱中症といい、熱中症は、労作性熱中症と、非労作性熱中症とに分類される。労作性熱中症は、仕事やスポーツなど暑熱環境下で激しい運動を続けることで、体温の上昇と脱水を招き高温による臓器障害をきたすものであり、主に屋外や炎天下で、若年~中年の特に男性が発症しやすい。非労作性熱中症は、古典的熱中症ともよばれ、日常生活中の熱中症であり、例えば、長風呂やサウナ、エアコンのきれている真夏の車内での発症や、連日の猛暑日・熱帯夜により数日かかって徐々に悪化する症状であり、主に屋内で、高齢者や乳児・幼児が罹患しやすい。本発明の好ましい態様によれば、暑熱環境は非運動時の暑熱環境である。
“Heat environment” refers to a hot environment that affects the body, such as summer heat. For example, a high temperature and high humidity environment such as indoors where the temperature is around 38 ° C. and the humidity is around 60.0%, and the heat index ((WBGT (wet bulb black temperature) Wet Globe Temperature)) is 25 in daily life. An environment that is at least 21 degrees in an exercise environment. Heat stroke is a general term for organ damage caused by deficiencies in the body's water and electrolytes (such as sodium and potassium) and hyperthermia itself, which occurs in a hot environment. Heat stroke is divided into exertional heat stroke and non-working heat stroke. being classified. Work-related heat stroke is caused by continued exercise in hot environments such as work and sports, leading to increased body temperature and dehydration, causing organ damage due to high temperatures. Men are particularly susceptible. Non-working heat stroke, also known as classic heat stroke, is a heat stroke in daily life, such as onset in a midsummer car with long baths, saunas, and air conditioners, or on extremely hot and tropical nights every day. It is a symptom that gradually worsens over several days, and is likely to affect older people, infants, and infants mainly indoors. According to a preferred aspect of the present invention, the hot environment is a non-exercise hot environment.
本発明の発汗促進用組成物を摂取する対象には、暑熱環境下における発汗促進による体温調整を必要とする汗腺を有する対象であれば、特に制限されない。対象には、ヒトだけでなく、ヒト以外の動物(例えば、馬、牛などの家畜、犬、猫などの愛玩動物、動物園などで飼育されている鑑賞動物)も包含される。
The subject ingesting the composition for promoting sweating of the present invention is not particularly limited as long as it has a sweat gland that requires body temperature adjustment by promoting sweating in a hot environment. The target includes not only humans but also animals other than humans (for example, domestic animals such as horses and cows, pets such as dogs and cats, appreciation animals kept in zoos, etc.).
本発明の発汗促進用組成物は、摂取すると、非運動時であっても、発汗を促進することができる。ここで、「非運動時」とは、運動による急激な糖質、脂質、タンパク質のエネルギー変換に伴う体温上昇などがない状態をいい、日常生活、例えば、長風呂、サウナ、エアコンのきれている真夏の車内、猛暑日、熱帯夜への曝露を包含する。
¡When ingested, the composition for promoting sweating of the present invention can promote sweating even when not exercising. Here, “when not exercising” refers to a state where there is no sudden increase in body temperature due to energy conversion of carbohydrates, lipids, and proteins due to exercise, and daily life such as long baths, saunas, and air conditioners are exhausted. Includes exposure to midsummer cars, hot days, and tropical nights.
発汗促進効果(作用、機能)とは、本発明の発汗促進用組成物により、暑熱環境において、非運動時であっても、発汗を促進することを意味する。ここで、発汗促進効果は、後述する実施例1に示されるような発汗量の測定によって確認することができ、具体的には、運動負荷を与えない暑熱環境における順応性試験において、サウナ負荷開始後20分の時点において、本発明の発汗促進用組成物を摂取しなかった場合と比較して、摂取した場合の発汗量平均上昇量が高いと、有意であると判断することができる(実施例1参照)。
The sweating promoting effect (action, function) means that the composition for promoting sweating of the present invention promotes sweating even in a hot environment even when not exercising. Here, the sweating promoting effect can be confirmed by measuring the amount of sweating as shown in Example 1 to be described later. Specifically, in the adaptability test in a hot environment where no exercise load is applied, the start of sauna load is started. After 20 minutes, it can be determined that the sweating average increase when ingested is higher than that when the composition for promoting perspiration of the present invention is not ingested. See Example 1).
本発明に用いられる「乳タンパク質」は、乳由来のタンパク質であれば、特に制限されず、例えば、ホエイタンパク質(乳清タンパク質)、カゼインタンパク質、ホエイタンパク質分解物、カゼインタンパク質分解物、ペプチド、または非タンパク態窒素成分を特定の濃度(含量)で含んでいるものが挙げられ、好ましくは、溶解性が良好な点でホエイタンパク質である。
The “milk protein” used in the present invention is not particularly limited as long as it is a milk-derived protein. For example, whey protein (whey protein), casein protein, whey protein degradation product, casein protein degradation product, peptide, or Examples include those containing a non-protein nitrogen component at a specific concentration (content), and preferably a whey protein in terms of good solubility.
「乳タンパク質」は、別々に分離や精製された、ホエイタンパク質、カゼインタンパク質、ホエイタンパク質分解物、カゼインタンパク質分解物、ペプチド、または非タンパク態窒素成分を特定の濃度になるように混合したものであってもよいし、あるいは、別々に分離や精製されていない、ホエイタンパク質、カゼインタンパク質、ホエイタンパク質分解物、カゼインタンパク質分解物、ペプチド、または非タンパク態窒素成分を既に特定の濃度で含んでいる原料(素材)や飲食品などを用いてもよい。このとき、本発明に用いられる「乳タンパク質」では、ホエイタンパク質、カゼインタンパク質、ホエイタンパク質分解物、カゼインタンパク質分解物、ペプチド、非タンパク態窒素成分の分離工程や精製工程を必要とせず、それらの製造費が安価である点で、ホエイタンパク質、カゼインタンパク質、ホエイタンパク質分解物、カゼインタンパク質分解物、またはペプチドおよび非タンパク態窒素成分を含んでいる原料や飲食品などを主要な成分とし、必要に応じて、別々に精製されたホエイタンパク質、カゼインタンパク質、ホエイタンパク質分解物、カゼインタンパク質分解物、またはペプチドおよび非タンパク態窒素成分を特定の濃度になるように混合して用いることが好ましい。
“Milk protein” is a mixture of whey protein, casein protein, whey protein degradation product, casein protein degradation product, peptide, or non-protein nitrogen component that has been separately separated and purified to a specific concentration. May contain whey protein, casein protein, whey proteolysate, casein proteolysate, peptide, or non-protein nitrogen component at a specific concentration, which may or may not be separately separated or purified You may use a raw material (material), food-drinks, etc. At this time, the “milk protein” used in the present invention does not require a separation step or purification step of whey protein, casein protein, whey protein degradation product, casein protein degradation product, peptide, or non-protein nitrogen component. In terms of low manufacturing costs, the main ingredients are foods and foods that contain whey protein, casein protein, whey protein degradation product, casein protein degradation product, or peptide and non-protein nitrogen components. Accordingly, it is preferable to use separately purified whey protein, casein protein, whey protein degradation product, casein protein degradation product, or peptide and non-protein nitrogen components so as to have a specific concentration.
カゼインタンパク質と別々に分離や精製されたホエイタンパク質には、例えば、ホエイの原液(甘性ホエイ、酸ホエイなど)、その濃縮物、その乾燥物(ホエイ粉)、その凍結物など、およびこれらの還元溶液などを用いることができる。さらに、脱塩ホエイ、ホエイタンパク質濃縮物(WPC)、ホエイタンパク質精製物(WPI)、α―ラクトアルブミン(α-La)、β-ラクトグロブリン(β-Lg)、免疫グロブリン、ラクトフェリンなど、および、これらの還元溶液を用いることができる。なお、ホエイタンパク質分解物には、前記のカゼインタンパク質と別々に分離や精製されたホエイタンパク質の加水分解物など、および、この還元溶液などを用いることができる。そして、ホエイタンパク質と別々に分離や精製されたカゼインタンパク質には、例えば、カゼインの分離物(フレッシュチーズなどのナチュラルチーズ、ナトリウムカゼイネート、カルシウムカゼイネートなど)、その濃縮物、その乾燥物、その凍結物など、および、これらの還元溶液などを用いることができる。さらに、α-カゼイン、β-カゼイン、к-カゼインなどの精製物、および、これらの還元溶液を用いることができる。なお、カゼインタンパク質分解物には、前記のホエイタンパク質と別々に分離や精製されたカゼインタンパク質の加水分解物など、および、この還元溶液などを用いることができる。また、ホエイタンパク質とカゼインタンパク質とを既に特定の濃度で含んでいる原料や飲食品には、例えば、生乳、殺菌乳(牛乳など)、脱脂乳、成分調整牛乳、加工乳、乳製品(濃縮乳、粉乳、練乳、発酵乳(ヨーグルト、ナチュラルチーズなど)、乳酸菌飲料、プロセスチーズ類、アイスクリーム類、クリーム類)、乳タンパク質濃縮物(MPC)、その濃縮物、その乾燥物、その凍結物、その加水分解物など、および、これらの還元溶液などを用いることができる。このとき、これらには、市販品を入手して用いてもよいし、自ら調製して用いてもよい。
Whey proteins separated and purified separately from casein protein include, for example, whey stock solutions (sweet whey, acid whey, etc.), concentrates, dried products (whey powder), frozen products, etc. A reducing solution or the like can be used. Furthermore, desalted whey, whey protein concentrate (WPC), whey protein purified product (WPI), α-lactalbumin (α-La), β-lactoglobulin (β-Lg), immunoglobulin, lactoferrin, etc., and These reducing solutions can be used. As the whey protein degradation product, a hydrolyzate of whey protein separated and purified separately from the above casein protein, a reduced solution thereof, and the like can be used. Casein protein separated and purified separately from whey protein includes, for example, casein isolate (natural cheese such as fresh cheese, sodium caseinate, calcium caseinate), its concentrate, its dried product, its Frozen products and the like, and reducing solutions thereof can be used. Furthermore, purified products such as α-casein, β-casein, and к-casein, and reducing solutions thereof can be used. In addition, as a casein protein degradation product, a hydrolyzate of casein protein separated and purified separately from the whey protein, a reduced solution thereof, and the like can be used. In addition, raw materials and foods and drinks that already contain whey protein and casein protein at specific concentrations include, for example, raw milk, pasteurized milk (such as milk), skim milk, component-adjusted milk, processed milk, and dairy products (concentrated milk). , Powdered milk, condensed milk, fermented milk (yogurt, natural cheese, etc.), lactic acid bacteria beverages, processed cheeses, ice creams, creams), milk protein concentrate (MPC), its concentrate, its dried product, its frozen product, A hydrolyzate thereof, a reducing solution thereof or the like can be used. At this time, you may obtain and use a commercial item for these, and may prepare and use it for themselves.
本発明の発汗促進用組成物は、乳タンパク質を有効成分としているため、一般のタンパク質より体内への吸収がよく、血流量の増加や水分の貯留が長く保たれる。そのため、摂取期間が短くても、高い発汗促進効果を得ることができる。
Since the composition for promoting sweating of the present invention contains milk protein as an active ingredient, the composition is better absorbed into the body than general proteins, and increases blood flow and retains water for a long time. Therefore, even if the intake period is short, a high sweating promoting effect can be obtained.
本発明の好ましい態様によれば、本発明の発汗促進用組成物は、ビタミンB類および/またはビタミンCをさらに含んでいてもよい。
According to a preferred embodiment of the present invention, the composition for promoting sweating of the present invention may further contain vitamins B and / or vitamin C.
本発明に用いられる「ビタミンB類」には、ビタミンB1、B2、B6、B12、ナイアシン、パントテン酸、葉酸およびビオチンの8種類が挙げられる。これらは1種を用いてもよいし、2種以上を組合せて用いてもよい。ビタミンB類は、好ましくは、ビタミンB1、B2、B6、B12、ナイアシン、パントテン酸および葉酸であり、より好ましくは、ビタミンB1、B2、B6およびナイアシンである。ビタミンB類は、乳タンパク質と共に摂取されることにより、乳タンパク質の代謝を補助することができる。
“Vitamin B” used in the present invention includes eight types of vitamins B1, B2, B6, B12, niacin, pantothenic acid, folic acid and biotin. These may be used alone or in combination of two or more. The vitamin Bs are preferably vitamins B1, B2, B6, B12, niacin, pantothenic acid and folic acid, more preferably vitamins B1, B2, B6 and niacin. Vitamin Bs can assist milk protein metabolism by being taken with milk protein.
ビタミンB類は、その総量として、乳タンパク質量に対して、ビタミンB類:乳タンパク質量比が1:30000~1:1000となるように添加することが望ましく、好ましくは2:30000~2:1000となるように添加する。好ましくは、ビタミンB類がビタミンB1および/又はビタミンB2の場合には、ビタミンB1および/又はビタミンB2:乳タンパク質量比が1:30000~1:1000となるように添加することが望ましく、好ましくは2:30000~2:1000となるように添加する。
The total amount of vitamin B is desirably added so that the ratio of vitamin B: milk protein amount is from 1: 30000 to 1: 1000, preferably from 2: 30000 to 2: Add to 1000. Preferably, when the vitamin B is vitamin B1 and / or vitamin B2, it is desirable that the vitamin B1 and / or vitamin B2: milk protein amount ratio is 1: 30000 to 1: 1000. Is added so as to be 2: 30000-2: 1000.
本発明に用いられる「ビタミンC」は、水溶性ビタミンの1種であり、化学的には、L-アスコルビン酸を指す。ビタミンCによりタンパク質合成を促進することができる。ビタミンCは、天然のものでもよいし、合成されたものであってもよい。
“Vitamin C” used in the present invention is a kind of water-soluble vitamin, and chemically refers to L-ascorbic acid. Vitamin C can promote protein synthesis. Vitamin C may be natural or synthesized.
ビタミンCは、乳タンパク質含量に対して、ビタミンC:乳タンパク質量比が、1:3000となるように添加することが好ましく、より好ましくは1:300、さらに好ましくは、1:30となるように添加する。
Vitamin C is preferably added so that the ratio of vitamin C: milk protein to the milk protein content is 1: 3000, more preferably 1: 300, and even more preferably 1:30. Add to.
本発明のより好ましい態様によれば、本発明の発汗促進用組成物は、乳タンパク質と、ビタミンB類と、ビタミンCとを有効成分として含んでなる。さらに好ましい態様によれば、本発明の発汗促進用組成物は、乳タンパク質と、ビタミンB1、ビタミンB2、ナイアシン、ビタミンB6、葉酸およびパントテン酸から選択される1種以上のビタミンB類と、ビタミンCとを有効成分として含んでなる。さらに好ましい態様によれば、本発明の発汗促進用組成物は、乳タンパク質と、ビタミンB1、ビタミンB2、ナイアシン、およびビタミンB6から選択される1種以上のビタミンB類と、ビタミンCとを有効成分として含んでなる。さらに好ましい態様によれば、本発明の発汗促進用組成物は、乳タンパク質と、ビタミンB1およびビタミンB2から選択される1種以上のビタミンB類と、ビタミンCとを有効成分として含んでなる。
According to a more preferred embodiment of the present invention, the composition for promoting sweating of the present invention comprises milk protein, vitamin Bs, and vitamin C as active ingredients. According to a further preferred embodiment, the composition for promoting sweating of the present invention comprises milk protein, one or more vitamin Bs selected from vitamin B1, vitamin B2, niacin, vitamin B6, folic acid and pantothenic acid, and vitamins. C as an active ingredient. According to a further preferred aspect, the composition for promoting sweating of the present invention is effective in milk protein, at least one vitamin B selected from vitamin B1, vitamin B2, niacin, and vitamin B6, and vitamin C. Comprising as an ingredient. According to a more preferred embodiment, the composition for promoting sweating of the present invention comprises milk protein, one or more vitamin Bs selected from vitamin B1 and vitamin B2, and vitamin C as active ingredients.
本発明の一つの態様によれば、本発明の発汗促進用組成物は、発汗促進効果を妨げない限り、他の成分を含んでいてもよい。他の成分としては、ナトリウム、カリウム、鉄、カルシウム、マグネシウムなどが挙げられる。また、本発明の発汗促進用組成物は、乳タンパク質以外のタンパク質、アミノ酸を含んでいてもよい。
According to one aspect of the present invention, the composition for promoting sweating of the present invention may contain other components as long as the effect of promoting sweating is not hindered. Examples of other components include sodium, potassium, iron, calcium, and magnesium. Moreover, the composition for promoting perspiration of the present invention may contain a protein other than milk protein and an amino acid.
本発明の発汗促進用組成物を対象に摂取させる方法(あるいは投与する方法)は、経口摂取(あるいは経口投与)、経腸投与、胃ろうなどから、その対象および用途により、適宜選択することができるが、好ましくは経口摂取(あるいは経口投与)である。
The method (or method of administration) for ingesting the composition for promoting sweating of the present invention to a subject can be appropriately selected from oral ingestion (or oral administration), enteral administration, gastric fistula and the like depending on the subject and application. Although it can, it is preferably taken orally (or orally).
本発明の発汗促進用組成物は、発汗を促進することにより、暑熱環境下においても、深部体温に大きな変化を与えないことができる。すなわち、本発明の発汗促進用組成物は、暑熱環境下における深部体温調節用組成物として用いることもできる。
The composition for promoting sweating according to the present invention can prevent perspiration from being greatly changed even in a hot environment by promoting sweating. That is, the composition for promoting sweating of the present invention can also be used as a composition for regulating body temperature in a hot environment.
また、本発明の発汗促進用組成物は、発汗を促進することにより、深部体温を調節することができ、ひいては、熱中症の予防および緩和を実現することができる。すなわち、本発明の発汗促進用組成物は、熱中症の予防剤および/または治療剤として用いることができ、好ましくは非労作性熱中症の予防剤および/または治療剤として用いることができる。
Moreover, the composition for promoting sweating of the present invention can regulate the deep body temperature by promoting sweating, and thus can prevent and alleviate heat stroke. That is, the composition for promoting sweating of the present invention can be used as a prophylactic and / or therapeutic agent for heat stroke, and preferably as a prophylactic and / or therapeutic agent for non-working heat stroke.
さらに、本発明の発汗促進用組成物は、発汗を促進することができるため、サウナやお風呂における、むくみの解消など、美容目的でのデトックス効果を得ることができる。すなわち、本発明の発汗促進用組成物は、デトックス促進用組成物、むくみ改善用組成物としても用いることができる。本明細書において「デトックス」とは、体内から毒素を排泄する作用を意味する。すなわち、食物や空気等の環境から微量摂取することによって体内に徐々に蓄積される有害物質や毒素を、発汗、排便および排尿等により体外に排出させることをいう。
Furthermore, since the composition for promoting sweating of the present invention can promote sweating, a detox effect for beauty purposes such as elimination of swelling in a sauna or bath can be obtained. That is, the composition for promoting sweating of the present invention can also be used as a composition for promoting detox and a composition for improving swelling. As used herein, “detox” means the action of excreting toxins from the body. That is, it means that harmful substances and toxins gradually accumulated in the body by ingesting a trace amount from the environment such as food and air are discharged outside the body by sweating, defecation and urination.
本発明の発汗促進用組成物は、その効果が奏される限り、どのような形態であってもよく、例えば、固体状(粉末状、顆粒状、カプセル状、ブロック状など)、液状、ゲル状、糊状、ペースト状などの形態をとることができる。本発明の発汗促進用組成物は、保存性や携帯性を高めることができる点で、固体状である。
The composition for promoting sweating of the present invention may be in any form as long as the effect is exerted, for example, solid (powder, granule, capsule, block, etc.), liquid, gel , Paste, paste and the like. The composition for promoting sweating of the present invention is in a solid form in that it can improve storage stability and portability.
本発明の一つの実施態様によれば、本発明の発汗促進用組成物は、乳タンパク質を含み、一日当たりの摂取量が、乳タンパク質のタンパク質量として、0.5g以上/kg体重となるように摂取されることが望ましく、好ましくは0.5~10g/kg体重、より好ましくは0.5~8g/kg体重、さらに好ましくは0.5~6g/kg体重となるように摂取される。また、本発明の別の好ましい実施態様によれば、本発明の発汗促進用組成物において、乳タンパク質のタンパク質含量が一食当たり、好ましくは、0.5g以上/kg体重となるように摂取され、より好ましくは0.5~1.6g/kg体重であり、さらに好ましくは0.5~1.2g/kg体重、より好ましくは0.5~1g/kg体重、さらに好ましくは0.5~0.7g/kg体重となるように摂取される。ここで、対象の代表的な体重は、60kgと見積もっている。
According to one embodiment of the present invention, the composition for promoting sweating of the present invention contains milk protein, and the daily intake is 0.5 g or more / kg body weight as the protein amount of milk protein. Ingested, preferably 0.5 to 10 g / kg body weight, more preferably 0.5 to 8 g / kg body weight, still more preferably 0.5 to 6 g / kg body weight. According to another preferred embodiment of the present invention, the composition for promoting sweating of the present invention is ingested so that the protein content of milk protein is preferably 0.5 g / kg body weight or more per serving. More preferably 0.5 to 1.6 g / kg body weight, still more preferably 0.5 to 1.2 g / kg body weight, more preferably 0.5 to 1 g / kg body weight, still more preferably 0.5 to Ingested to a weight of 0.7 g / kg. Here, the representative weight of the subject is estimated to be 60 kg.
本発明の好ましい実施態様によれば、本発明の発汗促進用組成物は、乳タンパク質とビタミンB類および/またはビタミンCとを含み、一日当たりの摂取量が、乳タンパク質の量として、5g以上/kg体重となるように摂取されることが望ましく、好ましくは5~10g/kg体重、より好ましくは5~8g/kg体重、さらに好ましくは5~6g/kg体重となるように摂取される。また、本発明の別の好ましい実施態様によれば、本発明の発汗促進用組成物は、乳タンパク質とビタミンB類および/またはビタミンCとを含み、一日当たりの摂取量が、乳タンパク質の量として、0.5g以上/kg体重となるように摂取されることが望ましく、好ましくは0.5~10g/kg体重、より好ましくは0.5~8g/kg体重、さらに好ましくは0.5~6g/kg体重となるように摂取される。また、本発明のさらに別の好ましい実施態様によれば、本発明の発汗促進用組成物は、乳タンパク質とビタミンB類および/またはビタミンCとを含み、乳タンパク質のタンパク質含量が一食当たり、好ましくは、0.5g以上/kg体重となるように摂取され、より好ましくは0.5~1.6g/kg体重であり、さらに好ましくは0.5~1.2g/kg体重、より好ましくは0.5~1g/kg体重、さらに好ましくは0.5~0.7g/kg体重となるように摂取される。この場合、ビタミンB類は、0.0015mg以上/kg体重となるように摂取されることが望ましく、好ましくは、0.0015~2mg/kg体重、より好ましくは0.015~1mg/kg体重、さらに好ましくは0.03~0.7mg/kg体重となるように摂取され、ビタミンCは、0.15mg以上/kg体重となるように摂取されることが望ましく、好ましくは、0.8~50mg/kg体重、より好ましくは1.5~35mg/kg体重、さらに好ましくは8~25mg/kg体重となるように摂取される。ここで、対象の代表的な体重は、60kgと見積もっている。
According to a preferred embodiment of the present invention, the composition for promoting sweating of the present invention comprises milk protein and vitamins B and / or vitamin C, and the daily intake is 5 g or more as the amount of milk protein. / Kg body weight is desirable, preferably 5 to 10 g / kg body weight, more preferably 5 to 8 g / kg body weight, still more preferably 5 to 6 g / kg body weight. According to another preferred embodiment of the present invention, the composition for promoting sweating of the present invention comprises milk protein and vitamins B and / or vitamin C, and the daily intake is the amount of milk protein. As mentioned above, it is desirable to take in so that the body weight is 0.5 g or more / kg body weight, preferably 0.5 to 10 g / kg body weight, more preferably 0.5 to 8 g / kg body weight, further preferably 0.5 to Ingested to reach 6 g / kg body weight. According to still another preferred embodiment of the present invention, the composition for promoting sweating of the present invention comprises milk protein and vitamins B and / or vitamin C, and the protein content of the milk protein is per serving, Preferably, it is taken so as to be 0.5 g or more / kg body weight, more preferably 0.5 to 1.6 g / kg body weight, still more preferably 0.5 to 1.2 g / kg body weight, more preferably Ingested so as to be 0.5 to 1 g / kg body weight, more preferably 0.5 to 0.7 g / kg body weight. In this case, vitamin Bs are desirably ingested so as to be 0.0015 mg / kg body weight or more, preferably 0.0015 to 2 mg / kg body weight, more preferably 0.015 to 1 mg / kg body weight, More preferably, it is taken to be 0.03 to 0.7 mg / kg body weight, and vitamin C is desirably taken to be 0.15 mg or more / kg body weight, preferably 0.8 to 50 mg. / Kg body weight, more preferably 1.5 to 35 mg / kg body weight, still more preferably 8 to 25 mg / kg body weight. Here, the representative weight of the subject is estimated to be 60 kg.
本発明の別の実施態様によれば、例えば、本発明の発汗促進用組成物は、一食当たりの単位包装形態からなり、該単位包装形態中に、一食摂取量として乳タンパク質の量として、30g以上に調整したものが望ましく、好ましくは30~100g、より好ましくは30~80g、さらに好ましくは30~60g、さらに好ましくは30~40gに調整してなるものである。「一食当たりの単位包装形態」からなるとは、一食当たりの摂取量があらかじめ定められた形態のものであり、例えば、特定量を経口摂取し得る食品として、一般食品のみならず健康補助食品、保健機能食品、サプリメント、飲料(ドリンク剤など)などの形態を意味する。「一食当たりの単位包装形態」では、例えば、粉末状・顆粒状・カプセル状・ブロック状の固体状の食品、液状の飲料、ゲル状・糊状・ペースト状のゼリーなどの場合には、金属缶、ガラスビン(ボトルなど)、プラスティック容器(ペットボトルなど)、パック、パウチ、フィルム容器、紙箱などの包装容器で特定量(用量)を規定できる形態、あるいは、一食当たりの摂取量(用法、用量)を包装容器やホームページなどに表示することで特定量を規定できる形態が挙げられる。
According to another embodiment of the present invention, for example, the composition for promoting sweating of the present invention comprises a unit packaging form per serving, and the amount of milk protein as a meal intake is included in the unit packaging form. And adjusted to 30 g or more, preferably 30 to 100 g, more preferably 30 to 80 g, still more preferably 30 to 60 g, still more preferably 30 to 40 g. “Contains a unit packaging form per meal” is a form in which the intake per meal is determined in advance, for example, as a food that can be ingested in a specific amount, not only general foods but also health supplements , Health functional foods, supplements, beverages (drinks, etc.). In "unit packaging form per meal", for example, in the case of powdery, granular, capsule, block-like solid food, liquid beverage, gel-like, paste-like, paste-like jelly, Forms that can specify a specific amount (dose) in packaging containers such as metal cans, glass bottles (such as bottles), plastic containers (such as plastic bottles), packs, pouches, film containers, paper boxes, etc., or intake per serving (usage) , Dose) can be specified on a packaging container or a homepage, and the specific amount can be specified.
本発明の好ましい実施態様によれば、本発明の発汗促進用組成物は、一食当たりの単位包装形態中に、さらにビタミンB類および/またはビタミンCを含んでなり、この場合、ビタミンB類は、一食摂取量として、0.1mg以上に調整したものが望ましく、好ましくは0.1~100mg、より好ましくは1~50mg、さらに好ましくは2~40mgに調整してなり、ビタミンCは、一食摂取量として、10mg以上に調整したものが望ましく、好ましくは50~3000mg、より好ましくは100~2000mg、さらに好ましくは500~1500mgに調整してなるものである。
According to a preferred embodiment of the present invention, the composition for promoting sweating of the present invention further comprises vitamin Bs and / or vitamin C in a unit package form per serving, in which case the vitamin Bs Is preferably adjusted to 0.1 mg or more, and preferably 0.1 to 100 mg, more preferably 1 to 50 mg, and even more preferably 2 to 40 mg. The intake per serving is preferably adjusted to 10 mg or more, preferably 50 to 3000 mg, more preferably 100 to 2000 mg, and still more preferably 500 to 1500 mg.
本発明の別の実施態様によれば、例えば、本発明の発汗促進用組成物は、その形態がいわゆる粉末状の健康補助食品である場合には、タンパク質量として30~100gの乳タンパク質、好ましくは該乳タンパク質とビタミンB類および/またはビタミンCとを含む組成物を一食当たり容量(用量)として、例えば、フィルム容器に入れられている(充填されている)形態が挙げられる。あるいは、タンパク質量として30~100gの乳タンパク質、好ましくは該乳タンパク質とビタミンB類および/またはビタミンCとを含む組成物が一食当たり摂取量(用法、用量)を包装容器やホームページなどに表示して、数食分(数回分)を一括した容量で、大容量の包装容器などに入れられている形態が挙げられる。
According to another embodiment of the present invention, for example, when the composition for promoting perspiration of the present invention is a so-called powdered health supplement, the protein amount is 30 to 100 g of milk protein, preferably For example, the composition containing the milk protein and vitamins B and / or vitamin C is used as a volume (dose) per serving, for example, in a form (filled) in a film container. Alternatively, the amount of protein (30 to 100 g of milk protein, preferably a composition containing the milk protein and vitamins B and / or vitamin C) may be displayed on a packaging container or homepage. And the form put into the packaging container etc. of a large capacity | capacitance by the capacity | capacitance of several meals (for several times) collectively is mentioned.
本発明の発汗促進用組成物を対象に摂取させる期間は、暑熱環境に曝露する前が望ましく、好ましくは曝露前3日間、より好ましくは曝露前5日間、さらに好ましくは曝露前7日間である。摂取期間が長くなればなるほど、体内の血流量を増加できる点で好ましく、その結果、発汗促進効果が高くなる。
The period during which the composition for promoting sweating of the present invention is ingested is preferably before exposure to a hot environment, preferably 3 days before exposure, more preferably 5 days before exposure, and even more preferably 7 days before exposure. The longer the intake period, the better the blood flow in the body can be increased, and as a result, the sweating promoting effect is enhanced.
本発明の一つの実施態様によれば、本発明の発汗促進用組成物は、そのまま単独で使用することができるが、発汗促進機能が発揮される限りにおいて、食品や医薬品などの種々の経口摂取用(経口投与用)の組成物に対して、原料(素材)や添加剤などとして含ませることもでき、発汗促進効果を有する組成物(例えば、医薬組成物や食品組成物)を得ることができる。本発明の発汗促進用組成物は、食事に添加しても味を損なわせるものではないため、通常の食事に添加したり、飲料に添加したりして、簡易に摂取することができる。
According to one embodiment of the present invention, the composition for promoting sweating of the present invention can be used alone as it is, but as long as the function of promoting sweating is exhibited, various oral intakes such as foods and pharmaceuticals can be used. Can be added as a raw material (material) or additive to a composition for oral administration (for oral administration), and a composition having a sweating promoting effect (for example, a pharmaceutical composition or a food composition) can be obtained. it can. Since the composition for promoting sweating of the present invention does not impair the taste even when added to a meal, it can be easily ingested by adding it to a normal meal or a drink.
本発明の一つの実施態様によれば、本発明の食品組成物において、他の成分として、例えば、水、糖質、脂質、ビタミン類、ミネラル類、有機酸、有機塩基、果汁、及びフレーバー類等を使用することができる。これらの他の成分は、2種以上を組み合わせて使用してもよく、あるいは、これらの合成品及び/又はこれらを多く含む食品を用いてもよい。
According to one embodiment of the present invention, in the food composition of the present invention, as other components, for example, water, carbohydrates, lipids, vitamins, minerals, organic acids, organic bases, fruit juices, and flavors Etc. can be used. These other components may be used in combination of two or more thereof, or a synthetic product thereof and / or a food containing a large amount thereof may be used.
糖質としては、食品組成物として使用されるものであれば特に制限されず、例えば、糖類、加工澱粉(テキストリンのほか、可溶性澱粉、ブリティッシュスターチ、酸化澱粉、澱粉エステル、澱粉エーテル等)、および食物繊維が挙げられる。
The sugar is not particularly limited as long as it is used as a food composition. For example, sugar, processed starch (in addition to text phosphorus, soluble starch, British starch, oxidized starch, starch ester, starch ether, etc.), And dietary fiber.
脂質としては、食品組成物として使用されるものであれば特に制限されず、例えば、ラード、魚油等、これらの分別油、水素添加油、およびエステル交換油等の動物性油脂;ならびに、パーム油、サフラワー油、コーン油、ナタネ油、ヤシ油、これらの分別油、水素添加油、およびエステル交換油等の植物性油脂が挙げられる。
The lipid is not particularly limited as long as it is used as a food composition. For example, animal oils such as lard, fish oil and the like, fractionated oils, hydrogenated oils and transesterified oils; and palm oil , Vegetable oils such as safflower oil, corn oil, rapeseed oil, coconut oil, fractionated oils thereof, hydrogenated oils, and transesterified oils.
ミネラル類としては、食品組成物として使用されるものであれば特に制限されず、例えば、カルシウム、カリウム、マグネシウム、ナトリウム、銅、鉄、銅、リン、マンガン、およびセレンが挙げられる。
The minerals are not particularly limited as long as they are used as food compositions, and examples thereof include calcium, potassium, magnesium, sodium, copper, iron, copper, phosphorus, manganese, and selenium.
有機酸としては、食品組成物として使用されるものであれば特に制限されず、例えば、リンゴ酸、クエン酸、乳酸、及び酒石酸が挙げられる。
The organic acid is not particularly limited as long as it is used as a food composition, and examples thereof include malic acid, citric acid, lactic acid, and tartaric acid.
有機塩基としては、食品組成物として使用されるものであれば特に制限されず、例えば、ヒスチジン等が挙げられる。
The organic base is not particularly limited as long as it is used as a food composition, and examples thereof include histidine.
果汁としては、食品組成物として使用されるものであれば特に制限されず、例えば、グレープ、オレンジ、マンゴー、グレープフルーツ、ブルーベリー、イチゴ、カシス、リンゴ、およびパイナップルが挙げられる。
The fruit juice is not particularly limited as long as it is used as a food composition, and examples thereof include grape, orange, mango, grapefruit, blueberry, strawberry, cassis, apple, and pineapple.
本発明の好ましい態様によれば、乳タンパク質、好ましくは乳タンパク質とビタミンB類および/またはビタミンCとを有効成分として含む、発汗促進用食品が提供される。「食品」(食品組成物)の形態は、溶液、懸濁液、乳濁液、粉末、固体成形物など、経口摂取可能な形態であればよく、特に限定されない。具体的には、レトルト食品、缶詰、電子レンジ食品、即席スープ類、フリーズドライ食品などの即席食品類;コーヒー飲料、茶飲料、粉末飲料、濃縮飲料;パン、パスタ、麺、ケーキミックス、パン粉などの小麦粉製品;クッキー、ビスケット、ケーキ、スナック、クラッカー、チョコレート、デザート菓子などの菓子類;調理ミックス、カレー・シチューの素類などの調味料;乳飲料、発酵乳(ヨーグルトなど)、乳酸菌飲料、ナチュラルチーズ、プロセスチーズ類、クリーム類、アイスクリーム類などの乳製品;シリアルなどの農産加工品;冷凍食品;流動食などが挙げられる。このような形態をとることで、心理的な障害を感じることなく摂取することができる。
According to a preferred embodiment of the present invention, there is provided a food for promoting sweating comprising milk protein, preferably milk protein and vitamins B and / or vitamin C as active ingredients. The form of “food” (food composition) is not particularly limited as long as it can be taken orally, such as a solution, a suspension, an emulsion, a powder, and a solid molded product. Specifically, instant foods such as retort foods, canned foods, microwave foods, instant soups, freeze-dried foods; coffee drinks, tea drinks, powdered drinks, concentrated drinks; bread, pasta, noodles, cake mixes, bread crumbs, etc. Flour products; cookies, biscuits, cakes, snacks, crackers, chocolates, desserts and other confectionery; cooking mixes, curry and stew ingredients; milk beverages, fermented milk (such as yogurt), lactic acid bacteria beverages, Examples include dairy products such as natural cheese, processed cheeses, creams and ice creams; processed agricultural products such as cereals; frozen foods; and liquid foods. By taking such a form, it can be taken without feeling a psychological disorder.
また、食品には、健康食品、機能性表示食品、栄養補助食品、特定保健用食品、病者用の食品、乳幼児用の調製粉乳、妊産婦用もしくは授乳婦用の粉乳、または暑熱環境における発汗促進のために用いられる物である旨の表示を付した食品のような分類のものも包含される。
Foods include health foods, functional labeling foods, dietary supplements, foods for specified health use, foods for the sick, infant formulas, milk powder for pregnant and lactating women, and promotion of sweating in hot environments It also includes those classified as foods with a label indicating that they are used for the purpose.
本発明の別の態様によれば、乳タンパク質、好ましくは乳タンパク質とビタミンB類および/またはビタミンCとを有効成分として含む、発汗促進用医薬品が提供される。「医薬品」(医薬組成物)とは、製剤化のために許容されうる添加剤を併用して、常法に従って、経口製剤または非経口製剤として調製したものである。医薬品が経口製剤の場合には、錠剤、散剤、細粒剤、顆粒剤、カプセル剤、丸剤、徐放剤などの固形製剤、溶液、懸濁液、乳濁液などの液状製剤の形態をとることができる。また、医薬品が非経口製剤の場合には、注射剤や座剤の形態をとることができる。なお、患者への摂取(投与)の簡易性の点からは、医薬品では、経口製剤であることが好ましい。ここで、製剤化のために許容されうる添加剤には、例えば、賦形剤、安定剤、防腐剤、湿潤剤、乳化剤、滑沢剤、甘味料、着色料、香料、緩衝剤、酸化防止剤、pH調整剤などが挙げられる。本発明の医薬品は、発汗促進を必要とする疾患、具体的には、熱中症(好ましくは非労作性熱中症)の治療または予防に用いることができる。
According to another aspect of the present invention, there is provided a drug for promoting sweating comprising milk protein, preferably milk protein and vitamin Bs and / or vitamin C as active ingredients. The “medicament” (pharmaceutical composition) is prepared as an oral preparation or a parenteral preparation according to a conventional method using additives that are acceptable for formulation. When the pharmaceutical is an oral preparation, it should be in the form of a solid preparation such as a tablet, powder, fine granule, granule, capsule, pill or sustained release, or a liquid preparation such as a solution, suspension or emulsion. Can take. Moreover, when a pharmaceutical is a parenteral formulation, it can take the form of an injection or a suppository. In terms of simplicity of ingestion (administration) to a patient, an oral preparation is preferable for a pharmaceutical product. Here, additives that are acceptable for formulation include, for example, excipients, stabilizers, preservatives, wetting agents, emulsifiers, lubricants, sweeteners, coloring agents, fragrances, buffers, antioxidants. Agents, pH adjusters and the like. The pharmaceutical agent of the present invention can be used for the treatment or prevention of diseases requiring the promotion of sweating, specifically heat stroke (preferably non-working heat stroke).
また、上述の通り、本発明の発汗促進用組成物は、乳タンパク質、好ましくは乳タンパク質とビタミンB類および/またはビタミンCとを含んでなる組成物の有効量と、任意の経口上許容可能な添加物とを配合することにより提供することができる。従って、本発明の別の態様によれば、乳タンパク質、好ましくは乳タンパク質とビタミンB類および/またはビタミンCとを含んでなる組成物の有効量を配合することを含む、発汗促進用組成物の製造方法が提供される。
In addition, as described above, the composition for promoting sweating of the present invention is an effective amount of a composition comprising milk protein, preferably milk protein and vitamins B and / or vitamin C, and any orally acceptable. Can be provided by blending with various additives. Therefore, according to another aspect of the present invention, a composition for promoting sweating comprising blending an effective amount of a milk protein, preferably a milk protein and a composition comprising vitamin Bs and / or vitamin C. A manufacturing method is provided.
本発明の別の実施態様によれば、乳タンパク質、好ましくは乳タンパク質とビタミンB類および/またはビタミンCとを含んでなる組成物の有効量を、それを必要とする暑熱環境における対象に摂取させることを含んでなる、発汗促進方法が提供される。本発明の別の好ましい態様によれば、発汗促進方法はヒトに対する医療行為を除くものとされる。ここで、「ヒトに対する医療行為」とは、医師等の処方を必要として、ヒトに対して医薬品を摂取させる(投与する)行為などを意味する。また、上記実施態様において、対象は好ましくは健常者である。
According to another embodiment of the invention, an effective amount of a composition comprising milk protein, preferably milk protein and vitamins B and / or vitamin C, is ingested by a subject in a hot environment in need thereof. A method of promoting perspiration comprising the step of: According to another preferred embodiment of the present invention, the method for promoting sweating excludes medical practice for humans. Here, the “medical action for humans” means an action that requires a doctor or the like to ingest (administer) a medicine to a human. In the above embodiment, the subject is preferably a healthy person.
また、本発明の発汗促進方法は、対象における発汗機能低下に関連した疾患または状態の改善に用いてもよい。従って、本発明の発汗促進方法は、好ましくは発汗機能低下に関連した疾患または状態の改善方法であり、より好ましくは熱中症、さらに好ましくは非労作性熱中症の改善方法である。ここで、「改善」とは、確立された疾患または状態を治療することだけでなく、将来確立される可能性のある疾患または状態を予防することをも含む。なお、本発明の発汗促進方法は、本願明細書における発汗促進用組成物の記載に従って実施することができる。
Further, the method for promoting sweating of the present invention may be used for improving a disease or a condition associated with a decrease in sweating function in a subject. Therefore, the method for promoting sweating of the present invention is preferably a method for ameliorating a disease or condition associated with reduced sweat function, more preferably a method for improving heat stroke, and more preferably a method for improving non-working heat stroke. As used herein, “amelioration” includes not only treating an established disease or condition, but also preventing a disease or condition that may be established in the future. The method for promoting sweating of the present invention can be carried out according to the description of the composition for promoting sweating in the present specification.
本発明の一つの好ましい実施態様によれば、本発明の発汗促進方法において、乳タンパク質のタンパク質含量が一食当たり、好ましくは、0.5g以上/kg体重となるように摂取(投与)され、より好ましくは0.5~1.6g/kg体重であり、さらに好ましくは0.5~1.2g/kg体重、より好ましくは0.5~1g/kg体重、さらに好ましくは0.5~0.7g/kg体重となるように摂取(投与)させることができる。ここで、対象の代表的な体重は、約60kgと見積もっている。
According to one preferred embodiment of the present invention, in the method for promoting perspiration of the present invention, milk protein is ingested (administered) so that the protein content per meal is preferably 0.5 g / kg body weight or more, More preferably, it is 0.5 to 1.6 g / kg body weight, more preferably 0.5 to 1.2 g / kg body weight, more preferably 0.5 to 1 g / kg body weight, still more preferably 0.5 to 0. It can be ingested (administered) to a weight of 7 g / kg. Here, the typical weight of the subject is estimated to be about 60 kg.
本発明の一つの好ましい実施態様によれば、本発明の発汗促進方法において、前記乳タンパク質をタンパク質含量で一食当たり30g以上となるように摂取させることができ、具体的には、30~100g、好ましくは30~80g、より好ましくは30~60g、さらに好ましくは30~40gとなるように摂取させることができる。
According to one preferred embodiment of the present invention, in the method for promoting sweating of the present invention, the milk protein can be ingested so that the protein content is 30 g or more per meal, specifically, 30 to 100 g. It can be ingested so that it is preferably 30 to 80 g, more preferably 30 to 60 g, and still more preferably 30 to 40 g.
本発明の一つ実施態様によれば、発汗促進のための、乳タンパク質の使用が提供される。本発明のより好ましい実施態様によれば、該使用は、ビタミンB類および/またはビタミンCと共に摂取するための使用である。本発明の一つの好ましい実施態様によれば、本発明の使用は、非治療的使用とされる。
According to one embodiment of the present invention, there is provided the use of milk protein to promote sweating. According to a more preferred embodiment of the invention, the use is for consumption with vitamins B and / or vitamin C. According to one preferred embodiment of the invention, the use of the invention is a non-therapeutic use.
本発明の一つの実施形態によれば、発汗促進用組成物の製造のための、乳タンパク質の使用が提供される。本発明のより好ましい実施態様によれば、該使用は、ビタミンB類および/またはビタミンCと共に摂取するための使用である。本発明の一つの好ましい実施態様によれば、該使用は、発汗促進用食品または医薬品の製造のための使用である。
According to one embodiment of the present invention, the use of milk protein for the production of a composition for promoting sweating is provided. According to a more preferred embodiment of the invention, the use is for consumption with vitamins B and / or vitamin C. According to one preferred embodiment of the invention, the use is for the production of a sweat promoting food or medicament.
本発明の一つの実施態様によれば、発汗を促進するための、乳タンパク質が提供される。本発明のより好ましい実施態様によれば、該乳タンパク質は、ビタミンB類および/またはビタミンCと共に使用される。
According to one embodiment of the present invention, a milk protein for promoting sweating is provided. According to a more preferred embodiment of the invention, the milk protein is used with vitamins B and / or vitamin C.
本発明を以下の例によって詳細に説明するが、本発明は、これらに限定されるものではない。
The present invention will be described in detail by the following examples, but the present invention is not limited thereto.
実施例1:暑熱環境下における順応性試験
下記表に示す組成(かつ1日当たりの摂取量)からなる発汗促進用組成物を対象者に7日間摂取させ、遠赤外線サウナにより作りだした暑熱環境下(サウナ室温38℃、湿度60%)における身体の順応性を検討した。ここで、ビタミンB類は、ビタミンB1、ビタミンB2、ナイアシン、ビタミンB6、ビタミンB12、葉酸およびパントテン酸を構成成分とするものを用いた。発汗促進用組成物の摂取は、通常の食事に、添加することにより行った。具体的には以下の方法により行った。 Example 1: Adaptability test in a hot environment In a hot environment created by a far-infrared sauna, the subject was ingested with a composition for promoting sweating consisting of the composition shown in the following table (and daily intake). The adaptability of the body at a sauna room temperature of 38 ° C. and a humidity of 60% was examined. Here, as vitamin B, those containing vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid and pantothenic acid as constituent components were used. Ingestion of the composition for promoting sweating was performed by adding it to a normal meal. Specifically, the following method was used.
下記表に示す組成(かつ1日当たりの摂取量)からなる発汗促進用組成物を対象者に7日間摂取させ、遠赤外線サウナにより作りだした暑熱環境下(サウナ室温38℃、湿度60%)における身体の順応性を検討した。ここで、ビタミンB類は、ビタミンB1、ビタミンB2、ナイアシン、ビタミンB6、ビタミンB12、葉酸およびパントテン酸を構成成分とするものを用いた。発汗促進用組成物の摂取は、通常の食事に、添加することにより行った。具体的には以下の方法により行った。 Example 1: Adaptability test in a hot environment In a hot environment created by a far-infrared sauna, the subject was ingested with a composition for promoting sweating consisting of the composition shown in the following table (and daily intake). The adaptability of the body at a sauna room temperature of 38 ° C. and a humidity of 60% was examined. Here, as vitamin B, those containing vitamin B1, vitamin B2, niacin, vitamin B6, vitamin B12, folic acid and pantothenic acid as constituent components were used. Ingestion of the composition for promoting sweating was performed by adding it to a normal meal. Specifically, the following method was used.
対象者
対象者は書面にて同意が得られた健常男子大学生10名とした。統計ソフトStat Flex ver.6(株式会社アーテック)を用いて、被験者のうち5名を、I期介入群、残りの5名をII期介入群とした。 Subjects The subjects were 10 healthy male university students with written consent. Statistical software Stat Flex ver. 6 (Artec Co., Ltd.), 5 of the subjects were the stage I intervention group and the remaining 5 were the stage II intervention group.
対象者は書面にて同意が得られた健常男子大学生10名とした。統計ソフトStat Flex ver.6(株式会社アーテック)を用いて、被験者のうち5名を、I期介入群、残りの5名をII期介入群とした。 Subjects The subjects were 10 healthy male university students with written consent. Statistical software Stat Flex ver. 6 (Artec Co., Ltd.), 5 of the subjects were the stage I intervention group and the remaining 5 were the stage II intervention group.
試験方法
研究デザインは、前向き介入試験、クロスオーバー試験とした。被験者には、はじめの7日間(I期)は、I期介入群には発汗促進用組成物を添加させた食事(試験食品)を摂取させ、II期介入群には発汗促進用組成物を摂取させなかった(通常の食事を継続した)。その後、2週間のウォッシュアウト期間を設けた。次の7日間(II期)は、I期介入群には発汗促進用組成物を摂取させず(通常の食事を継続した)、II期介入群には発汗促進用組成物を添加させた食事(試験食品)を摂取させた。試験期間中、水分や塩分の摂取量は制限しなかった。アルコール摂取は禁止した。 The study design was a prospective intervention study and a crossover study. For the first 7 days (Stage I), subjects ingested a diet (test food) supplemented with a sweat-promoting composition in the Stage I intervention group, and the sweating-promoting composition in the Stage II intervention group. Not ingested (continue normal diet). A two-week washout period was then established. For the next 7 days (stage II), the stage I intervention group did not take the composition for promoting sweating (continued normal diet), and the stage II intervention group had the composition for promoting sweating added (Test food) was ingested. During the study period, water and salt intake were not restricted. Alcohol consumption was prohibited.
研究デザインは、前向き介入試験、クロスオーバー試験とした。被験者には、はじめの7日間(I期)は、I期介入群には発汗促進用組成物を添加させた食事(試験食品)を摂取させ、II期介入群には発汗促進用組成物を摂取させなかった(通常の食事を継続した)。その後、2週間のウォッシュアウト期間を設けた。次の7日間(II期)は、I期介入群には発汗促進用組成物を摂取させず(通常の食事を継続した)、II期介入群には発汗促進用組成物を添加させた食事(試験食品)を摂取させた。試験期間中、水分や塩分の摂取量は制限しなかった。アルコール摂取は禁止した。 The study design was a prospective intervention study and a crossover study. For the first 7 days (Stage I), subjects ingested a diet (test food) supplemented with a sweat-promoting composition in the Stage I intervention group, and the sweating-promoting composition in the Stage II intervention group. Not ingested (continue normal diet). A two-week washout period was then established. For the next 7 days (stage II), the stage I intervention group did not take the composition for promoting sweating (continued normal diet), and the stage II intervention group had the composition for promoting sweating added (Test food) was ingested. During the study period, water and salt intake were not restricted. Alcohol consumption was prohibited.
I期(はじめの7日間)の前後およびII期の前後の計4回、遠赤外線サウナ負荷試験を実施した。
The far-infrared sauna load test was conducted a total of 4 times before and after the period I (first 7 days) and before and after the period II.
試験食品摂取時の一日当たりに付加される摂取エネルギーは、139kcalである。
The intake energy added per day when taking the test food is 139 kcal.
評価項目
サウナ負荷開始後の5分、10分、20分、30分の時点で評価を行った。サウナ負荷中は、深部体温を、体温モニター(テルモ株式会社、CM-210)を用いて測定した。深部体温の測定には、熱流補償法プローブを用いた。深部体温プローブを前額にテープとバンドにて装着した。深部体温平均上昇量として、サウナ入室前の3分間の深部体温の平均を基準値とし、サウナ負荷開始後5分、10分、20分、30分の時点における各30秒間の深部体温の平均と基準値の差を求めた。また、発汗量(mg/cm2/min)を発汗計(株式会社テクノサイエンス、TPL3520)を用いて測定した。センサヘッドを左前腕の肘に近い内側にテープにて装着した。発汗量平均上昇量(mg/cm2)としてサウナ入室前の3分間の発汗量の平均を基準値とし、サウナ負荷開始後5分、10分、20分、30分の時点における各30秒間の発汗量の平均と基準値との差を求めた。 Evaluation item Evaluation was performed at the time of 5 minutes, 10 minutes, 20 minutes, and 30 minutes after the start of sauna loading. During sauna loading, deep body temperature was measured using a body temperature monitor (Terumo Corporation, CM-210). A heat flow compensation probe was used to measure the deep body temperature. A deep body temperature probe was attached to the forehead with tape and a band. As an average amount of increase in deep body temperature, the average value of the deep body temperature for 3 minutes before entering the sauna is used as a reference value, and the average of the deep body temperature for 30 seconds at the time of 5 minutes, 10 minutes, 20 minutes, and 30 minutes after starting the sauna load The difference between the reference values was determined. In addition, the amount of sweat (mg / cm 2 / min) was measured using a sweat meter (Techno Science Co., Ltd., TPL3520). The sensor head was attached to the inside of the left forearm near the elbow with tape. The average increase in perspiration (mg / cm 2 ) is the average of perspiration for 3 minutes before entering the sauna, and it is 30 minutes each at 5 minutes, 10 minutes, 20 minutes and 30 minutes after the start of sauna loading. The difference between the average amount of sweating and the reference value was determined.
サウナ負荷開始後の5分、10分、20分、30分の時点で評価を行った。サウナ負荷中は、深部体温を、体温モニター(テルモ株式会社、CM-210)を用いて測定した。深部体温の測定には、熱流補償法プローブを用いた。深部体温プローブを前額にテープとバンドにて装着した。深部体温平均上昇量として、サウナ入室前の3分間の深部体温の平均を基準値とし、サウナ負荷開始後5分、10分、20分、30分の時点における各30秒間の深部体温の平均と基準値の差を求めた。また、発汗量(mg/cm2/min)を発汗計(株式会社テクノサイエンス、TPL3520)を用いて測定した。センサヘッドを左前腕の肘に近い内側にテープにて装着した。発汗量平均上昇量(mg/cm2)としてサウナ入室前の3分間の発汗量の平均を基準値とし、サウナ負荷開始後5分、10分、20分、30分の時点における各30秒間の発汗量の平均と基準値との差を求めた。 Evaluation item Evaluation was performed at the time of 5 minutes, 10 minutes, 20 minutes, and 30 minutes after the start of sauna loading. During sauna loading, deep body temperature was measured using a body temperature monitor (Terumo Corporation, CM-210). A heat flow compensation probe was used to measure the deep body temperature. A deep body temperature probe was attached to the forehead with tape and a band. As an average amount of increase in deep body temperature, the average value of the deep body temperature for 3 minutes before entering the sauna is used as a reference value, and the average of the deep body temperature for 30 seconds at the time of 5 minutes, 10 minutes, 20 minutes, and 30 minutes after starting the sauna load The difference between the reference values was determined. In addition, the amount of sweat (mg / cm 2 / min) was measured using a sweat meter (Techno Science Co., Ltd., TPL3520). The sensor head was attached to the inside of the left forearm near the elbow with tape. The average increase in perspiration (mg / cm 2 ) is the average of perspiration for 3 minutes before entering the sauna, and it is 30 minutes each at 5 minutes, 10 minutes, 20 minutes and 30 minutes after the start of sauna loading. The difference between the average amount of sweating and the reference value was determined.
暑熱環境モデルとして、遠赤外線サウナ ナチュラルスパ ゆったり1人用(株式会社神戸メディケア)を用いて室温を設定した。サウナ室温を38℃になるように設定した。また、サウナ室内の湿度として、加湿器(SIS株式会社、PIA HYBRID加湿器)を用いた。サウナ室内の湿度が60.0%前後になるように設定した。暑熱環境の曝露時間は遠赤外線サウナの使用安全基準内である30分間とした。また、サウナ入室中は、全対象者で同一素材の市販衣類を着衣させた。
As a hot environment model, a room temperature was set using a far-infrared sauna, natural spa, relaxing for one person (Kobe Medicare). The sauna room temperature was set to 38 ° C. A humidifier (SIS Corporation, PIA HYBRID humidifier) was used as the humidity in the sauna room. The humidity in the sauna room was set to be around 60.0%. The exposure time in the hot environment was 30 minutes, which is within the safety standards for using far-infrared saunas. In addition, while entering the sauna, all subjects wore commercial clothing of the same material.
統計解析
測定値は平均値±標準誤差(SE)で表した。統計解析には、IBM SPSS Statistics ver.20(日本アイ・ビー・エム株式会社)およびMicrosoft Excel 2013(日本マイクロソフト株式会社)を用いた。統計処理は、対応のあるt検定を用いて行った。有意水準として5%未満を有意差有りと判断した。 Statistical analysis measurement values were expressed as mean ± standard error (SE). For statistical analysis, IBM SPSS Statistics ver. 20 (Japan IBM Corporation) and Microsoft Excel 2013 (Japan Microsoft Corporation) were used. Statistical processing was performed using a paired t-test. A significance level of less than 5% was judged to be significant.
測定値は平均値±標準誤差(SE)で表した。統計解析には、IBM SPSS Statistics ver.20(日本アイ・ビー・エム株式会社)およびMicrosoft Excel 2013(日本マイクロソフト株式会社)を用いた。統計処理は、対応のあるt検定を用いて行った。有意水準として5%未満を有意差有りと判断した。 Statistical analysis measurement values were expressed as mean ± standard error (SE). For statistical analysis, IBM SPSS Statistics ver. 20 (Japan IBM Corporation) and Microsoft Excel 2013 (Japan Microsoft Corporation) were used. Statistical processing was performed using a paired t-test. A significance level of less than 5% was judged to be significant.
研究に同意が得られた対象者10名のうち2名について、被験者の意思および研究責任者の判断のため中止した。そのため8名に対してサウナ負荷を行い、8名を解析対象とした。
2) Among the 10 subjects who agreed to the study, 2 subjects were discontinued due to the subject's will and the judgment of the investigator. Therefore, sauna load was applied to 8 people, and 8 people were analyzed.
介入前後における深部体温平均上昇量の変化量の結果を図1に示す。
Figure 1 shows the results of changes in the average increase in deep body temperature before and after the intervention.
図1に示されるように、非摂取群(非介入)では深部体温平均上昇量の変化量は、サウナ負荷開始後5分の時点で0.04±0.02℃、10分の時点で0.08±0.03℃、20分の時点で0.18±0.02℃、30分の時点で0.20±0.02℃と、時間を経るごとに上昇した。一方で、発汗促進用組成物摂取群(介入)ではサウナ負荷開始後5分の時点で-0.01±0.04℃、10分の時点で-0.09±0.05℃、20分の時点で0.05±0.04℃、30分の時点で-0.06±0.05℃と変化し、ほとんど増加しなかった。従って、発汗促進用組成物摂取により、暑熱環境下において深部体温の上昇が抑制されたことが示された。
As shown in FIG. 1, in the non-ingestion group (non-intervention), the amount of change in the average increase in deep body temperature is 0.04 ± 0.02 ° C. at 5 minutes after the start of sauna loading, and 0 at 10 minutes 0.08 ± 0.03 ° C., 0.18 ± 0.02 ° C. at 20 minutes, 0.20 ± 0.02 ° C. at 30 minutes, and increased with time. On the other hand, in the sweat intake composition intake group (intervention), −0.01 ± 0.04 ° C. at 5 minutes after the start of sauna loading, −0.09 ± 0.05 ° C. at 20 minutes, 20 minutes It changed to 0.05 ± 0.04 ° C. at the time point of −0.06 ± 0.05 ° C. at the time point of 30 minutes and hardly increased. Therefore, it was shown that the increase in deep body temperature was suppressed by ingestion of the composition for promoting sweating in a hot environment.
また、介入前後における発汗量平均上昇量の変化量の結果を図2に示す。
In addition, the results of the amount of change in the average amount of sweating before and after the intervention are shown in FIG.
図2に示されるように、サウナ負荷開始後20分の時点において、非摂取群(非介入)では-0.48±0.16mg/cm2に対して、発汗促進用組成物摂取群(介入)では0.47±0.30mg/cm2であり、有意に高値を示した(p=0.02)。すなわち、発汗促進用組成物摂取により、暑熱環境下において発汗量が増加したことを確認した。
As shown in FIG. 2, at 20 minutes after the start of sauna loading, in the non-ingestion group (non-intervention), −0.48 ± 0.16 mg / cm 2 , the composition for promoting sweating (intervention) ) 0.47 ± 0.30 mg / cm 2 , indicating a significantly high value (p = 0.02). That is, it was confirmed that the amount of sweat increased in a hot environment by ingesting the composition for promoting sweating.
図1および図2に示されるように、本発明の発汗促進用組成物を摂取することによって、発汗量が上昇し深部体温の上昇が抑制されることが確認された。
As shown in FIG. 1 and FIG. 2, it was confirmed that by ingesting the composition for promoting sweating of the present invention, the amount of sweating is increased and the rise in deep body temperature is suppressed.
実施例2:発汗促進用組成物添加による味の変化
実施例1で用いた発汗促進用組成物を、食事(例えば、スープ、味噌汁、シチュウ)や飲料(例えば、カフェオレ、ミルクティー)に添加した場合の味への影響を確認した。具体的には、実施例1の試験食品の調製に従い、1日当たりの発汗促進用組成物を添加した食事や飲料と、非添加の食事や飲料とで味を比較した。その結果、発汗促進用組成物を添加した食事や飲料には、ほとんど味の変化は見られず、非添加の食事や飲料とほぼ同じ味であった。 Example 2: Change in taste due to addition of composition for promoting sweating The composition for promoting sweating used in Example 1 is added to meals (for example, soup, miso soup, stew) and beverages (for example, cafe au lait, milk tea) The effect on taste was confirmed. Specifically, according to the preparation of the test food of Example 1, the taste was compared between a meal or beverage to which the composition for promoting sweating per day was added and a non-added meal or beverage. As a result, almost no change in taste was seen in the meals and beverages to which the composition for promoting sweating was added, and the tastes were almost the same as those of the non-added foods and beverages.
実施例1で用いた発汗促進用組成物を、食事(例えば、スープ、味噌汁、シチュウ)や飲料(例えば、カフェオレ、ミルクティー)に添加した場合の味への影響を確認した。具体的には、実施例1の試験食品の調製に従い、1日当たりの発汗促進用組成物を添加した食事や飲料と、非添加の食事や飲料とで味を比較した。その結果、発汗促進用組成物を添加した食事や飲料には、ほとんど味の変化は見られず、非添加の食事や飲料とほぼ同じ味であった。 Example 2: Change in taste due to addition of composition for promoting sweating The composition for promoting sweating used in Example 1 is added to meals (for example, soup, miso soup, stew) and beverages (for example, cafe au lait, milk tea) The effect on taste was confirmed. Specifically, according to the preparation of the test food of Example 1, the taste was compared between a meal or beverage to which the composition for promoting sweating per day was added and a non-added meal or beverage. As a result, almost no change in taste was seen in the meals and beverages to which the composition for promoting sweating was added, and the tastes were almost the same as those of the non-added foods and beverages.
Claims (13)
- 乳タンパク質を有効成分として含んでなる、暑熱環境における発汗促進用組成物。 A composition for promoting sweating in a hot environment, comprising milk protein as an active ingredient.
- ビタミンB類をさらに含んでなる、請求項1に記載の発汗促進用組成物。 The composition for promoting sweating according to claim 1, further comprising vitamin Bs.
- ビタミンCをさらに含んでなる、請求項1または2に記載の発汗促進用組成物。 The composition for promoting sweating according to claim 1 or 2, further comprising vitamin C.
- 非運動時に使用するための、請求項1~3のいずれか一項に記載の発汗促進用組成物。 The composition for promoting sweating according to any one of claims 1 to 3, which is used during non-exercise.
- 一日当たりの摂取量が、乳タンパク質の量として0.5g以上/kg体重である、請求項1~4のいずれか一項に記載の発汗促進用組成物。 The composition for promoting sweating according to any one of claims 1 to 4, wherein the daily intake is 0.5 g or more / kg body weight as the amount of milk protein.
- 乳タンパク質がホエイタンパク質である、請求項1~5のいずれか一項に記載の発汗促進用組成物。 The composition for promoting sweating according to any one of claims 1 to 5, wherein the milk protein is whey protein.
- 一食当たりの単位包装形態からなり、該単位包装形態中に、一食摂取量として乳タンパク質の量として30g以上を含む、請求項1~6のいずれか一項に記載の発汗促進用組成物。 The composition for promoting sweating according to any one of Claims 1 to 6, comprising a unit package form per serving, wherein the unit package form contains 30 g or more of milk protein as a single food intake. .
- 非労作性熱中症予防に用いられる、請求項1~7のいずれか一項に記載の発汗促進用組成物。 The composition for promoting sweating according to any one of claims 1 to 7, which is used for preventing non-working heat stroke.
- 食品組成物である、請求項1~8のいずれか一項に記載の発汗促進用組成物。 The composition for promoting sweating according to any one of claims 1 to 8, which is a food composition.
- 乳タンパク質を含んでなる組成物の有効量を、それを必要とする対象に摂取させることを含んでなる、暑熱環境における発汗促進方法。 A method of promoting sweating in a hot environment, comprising allowing a subject in need thereof to take an effective amount of a composition comprising milk protein.
- 前記組成物が、ビタミンB類およびビタミンCからなる群から選択される少なくとも一つを含んでなる、請求項10に記載の方法。 The method according to claim 10, wherein the composition comprises at least one selected from the group consisting of vitamins B and vitamin C.
- 暑熱環境における発汗を促進するための、乳タンパク質。 Milk protein to promote sweating in hot environments.
- ビタミンB類およびビタミンCからなる群から選択される少なくとも一つと共に使用される、請求項12に記載の乳タンパク質。 The milk protein according to claim 12, which is used together with at least one selected from the group consisting of vitamins B and vitamin C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018559154A JPWO2018123873A1 (en) | 2016-12-28 | 2017-12-22 | Composition for promoting sweating |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-256460 | 2016-12-28 | ||
JP2016256460 | 2016-12-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018123873A1 true WO2018123873A1 (en) | 2018-07-05 |
Family
ID=62707560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2017/046151 WO2018123873A1 (en) | 2016-12-28 | 2017-12-22 | Composition for promoting perspiration |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPWO2018123873A1 (en) |
WO (1) | WO2018123873A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020138026A1 (en) | 2018-12-28 | 2020-07-02 | 株式会社林原 | Heat stress alleviation agent |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004137268A (en) * | 2002-09-27 | 2004-05-13 | Univ Shinshu | Accelerator for increasing amount of plasma |
JP2009235050A (en) * | 2008-03-06 | 2009-10-15 | Ss Pharmaceut Co Ltd | Pharmaceutical |
WO2015037719A1 (en) * | 2013-09-12 | 2015-03-19 | 株式会社明治 | Bodily moisture retaining agent |
-
2017
- 2017-12-22 JP JP2018559154A patent/JPWO2018123873A1/en active Pending
- 2017-12-22 WO PCT/JP2017/046151 patent/WO2018123873A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004137268A (en) * | 2002-09-27 | 2004-05-13 | Univ Shinshu | Accelerator for increasing amount of plasma |
JP2009235050A (en) * | 2008-03-06 | 2009-10-15 | Ss Pharmaceut Co Ltd | Pharmaceutical |
WO2015037719A1 (en) * | 2013-09-12 | 2015-03-19 | 株式会社明治 | Bodily moisture retaining agent |
Non-Patent Citations (2)
Title |
---|
"Countermeasure against heat-stroke is performed according to a period, in thirdth", GERIATRIC MEDICINE, vol. 52, no. 5, 2014, pages 519 - 525, ISSN: 0387-1088 * |
TANIGUCHI HIDEKI ET AL.: "Effect on Acclimation to intense heat by ingesting protein and Vitamin B group- enriched food : Meal intervention study using blind test for 7 days with respect to female volunteer college students", JAPANESE PHARMACOLOGY & THERAPEUTICS, vol. 44, no. 1, 2016, pages 73 - 83, ISSN: 0386-3603 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020138026A1 (en) | 2018-12-28 | 2020-07-02 | 株式会社林原 | Heat stress alleviation agent |
Also Published As
Publication number | Publication date |
---|---|
JPWO2018123873A1 (en) | 2019-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101484158B (en) | Senescence inhibitor | |
WO2015037720A1 (en) | Muscle repair promoter | |
AU2011210683A1 (en) | Nutritional powders comprising spray dried HMB | |
JP6728071B2 (en) | Muscle synthesis promoter | |
JP6551393B2 (en) | Weak preventive agent | |
CA2860642C (en) | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers | |
CN106028837B (en) | Methods and compositions for weight management using cinnamaldehyde and zinc | |
JPWO2017026429A1 (en) | Muscle synthesis promoter | |
JP6037595B2 (en) | Satiety induction composition and method for producing the same | |
WO2018123873A1 (en) | Composition for promoting perspiration | |
JP6430386B2 (en) | Body moisture retention agent | |
WO2018124202A1 (en) | Perspiration-promoting food composition | |
TW201635909A (en) | Fatigue ameliorating agent | |
WO2018199130A1 (en) | Composition for improving intellectual working ability and composition for improving cognitive ability | |
JP7383874B2 (en) | Composition for inhibiting endotoxin transfer into blood | |
WO2017146141A1 (en) | Rehydration agent | |
JP2015529470A (en) | Composition containing β-hydroxy-β-methylbutyric acid (METHYLBUTRYICACID) and use thereof | |
JP2019123672A (en) | Cancer patient muscle amount reduction suppression composition | |
JP2019099498A (en) | Composition for promoting lipid metabolism | |
CN107249615B (en) | Hot flash inhibitor | |
WO2018074415A1 (en) | Composition for improving protein efficiency ratio | |
JP2020200242A (en) | Composition for improving exercise tolerability | |
JP2019099495A (en) | Composition for promoting blood pressure fall | |
JP2018131417A (en) | Anemia preventing/improving composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17889023 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2018559154 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17889023 Country of ref document: EP Kind code of ref document: A1 |